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Frage nicht, was die Welt braucht.  
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denn was die Welt braucht, das sind Leute, die lebendig geworden sind. 
 
 
Howard Thurman (1899 - 1981) 
Amerikanischer Philosoph, Theologe, Autor und Bürgerrechtskämpfer 
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Abstract 
Cancer is associated with high individual and societal burden worldwide, caused 
not only by mortality but also by morbidity and physical impairment of the patients. In 
addition, cancer frequently causes major psychological distress. Although distress 
screening programs aim to ensure appropriate psycho-oncological support, cancer 
patients often do not use these services. Therefore, the majority of newly diagnosed 
cancer patients lack psychological support.  
The development and testing of the first web-based stress management 
intervention (STREAM: STREss-Aktiv-Mindern) for newly diagnosed cancer patients 
forms the main part of this thesis. The rationale for this early intervention was three-
fold: First, distress in patients with cancer peaks shortly after the diagnosis [Fang et al., 
2012], irrespective of the cancer type. Second, the period immediately after the 
diagnosis tends to be busy with diagnostic and therapeutic appointments. Therefore, 
self-management of time, location, and autonomy facilitated by web-based 
interventions might be of particular value to these patients [Andersson, 2016]. Third, 
successful early psychosocial interventions have shown a substantial potential to affect 
the course of the disease beyond psychosocial outcomes. 
Although various web-based psychological tools have been available for at least 
a decade, such instruments have retained their evolutionary character. Healthcare 
professionals often fear to lose the therapeutic relationship with the patient which is 
known to play a role in the therapeutic effectiveness (e.g. [Orlinsky et al., 1994]). In line 
with the growing literature on web-based interventions for many mental and physical 
diseases, we aimed to include those patients who are currently not reached by 
conventional support options by providing web-based support that does not exclude the 
helpful therapeutic relationship. 
Our findings showed that a web-based, minimal-contact stress management 
program is an attractive as well as time- and cost-effective way to provide psycho-
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oncological support to newly diagnosed cancer patients. Use of our tool resulted in 
significant and clinically relevant improvement of the patient’s quality of life (QoL) and 
distress reduction. 
1.  Preface 
The diagnosis of cancer inevitably changes the life of affected patients, both 
physically and emotionally. In Switzerland, around 40,000 people are diagnosed with 
cancer each year [Bundesamt für Statistik, 2016]. According to estimated incidences of 
cancer worldwide, more than 29 million new cases are expected in 2040 [Global Cancer 
Observatory, 2019]. The increasing cancer burden is due to several factors, including 
population growth and aging as well as the changing prevalence of certain causes of 
cancer linked to social and economic developments.  
A cancer diagnosis can turn a person’s life upside down from one day to the next, 
and nothing is the same as it used to be. While medical care for such patients is usually 
ensured, mental support may be insufficient. Mental needs may be manifested by 
feelings of being lost, disorientated, depressed, anxious, or even ashamed. These 
feelings can result in the patients’ withdrawal from social life and entrapment in circles 
of thoughts. Fears, both the realistic ones as well as exaggerated ones, may paralyze 
the patients and prevent them from taking personal action. In the course of time, this 
often leads to a poorer QoL for the patients.  
Cancer patients should receive tailored support during the early stages of their 
disease since this tends to be a highly vulnerable phase for affected individuals. This 
thesis is an integral part of an interdisciplinary research project conducted at the 
University of Basel to study the impact of non-drug interventions on treatment outcome 
in cancer patients. The project entitled “Non-drug interventions to enhance efficacy of 
drug treatment in cancer patients” was supported by the Swiss National Science 
Foundation (SNF) professorship funds awarded to Viviane Hess (Grant No. SNF 
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PP00P3_139155/1). In addition, Cancer Research Switzerland funded the contribution 
made by Corinne Urech (Grant No. KFS-3260-08-2013), and the Swiss Cancer League 
(“Krebsliga Schweiz”) provided financial support in connection with a study conducted 
by Diana Zwahlen (Swiss Cancer League; Grant No. 3186–02-2013). The latter project 
was entitled “Understanding why cancer patients accept or turn down psycho-
oncological support: A prospective observational study including patients’ and 
clinicians’ perspectives on communication about distress”  
This thesis is based on three publications accepted and published by peer-
reviewed scientific journals (see Section 4 for the published papers and appendix for 
the published study protocol of the STREAM-1 trial). Our studies aimed to investigate 
whether newly diagnosed cancer patients are in need of support to handle their difficult 
situation. Moreover, we tested the usability, feasibility, and efficacy of the web-based 
program STREAM, an intervention tool for newly diagnosed cancer patients. The 
German acronym was formed from STREss Aktiv Mindern (in English: active stress 
reduction). 
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2. Background 
2.1 Impact of cancer on distress and quality of life 
2.1.1 Distress 
The number of cancer patients is increasing steadily in Switzerland [Arndt et al., 
2016; Herrmann et al., 2013] and worldwide [Ferlay et al., 2019; Global Cancer 
Observatory, 2019]. Multimodal treatment regimens may prolong tumor-free survival 
times and extend the patient’s life expectancy. A diagnosis of cancer elicits high levels 
of distress in the majority of patients, and every second cancer patient suffers from 
clinically relevant psychosocial distress [Mehnert et al., 2014; Mehnert et al., 2018]. The 
National Comprehensive Cancer Network (NCCN) guidelines define distress as a 
multifactorial, unpleasant experience of a psychological (i.e. cognitive, behavioral, 
emotional), social, spiritual, and/or physical nature that may interfere with the ability to 
cope effectively with cancer, its physical symptoms, and its treatment. Distress extends 
along a continuum, ranging from normal feelings of vulnerability, sadness, and fears to 
problems that can become disabling, such as depression, anxiety, panic, social 
isolation, and existential and spiritual crises [National Comprehensive Cancer Network, 
2019]. Psychosocial distress encompasses emotional lability, rearranging of roles and 
responsibilities, change in appearance, change of plans, fear of recurrence, depression, 
and anxiety resulting in poorer QoL [Penedo et al., 2013; Rehse & Pukrop, 2003; Wu & 
Harden, 2015]. This might lead to a vicious cycle in that high levels of distress might 
reduce compliance with treatment and thus increase the side effects [Chambers et al., 
2012; Park & Gaffey, 2007]. In turn, this will lead to a poorer QoL and diminished 
treatment tolerability [Duijts et al., 2011; Luebbert et al., 2001]. In the worst case, 
psychological distress may negatively affect the course of disease [Kim et al., 2017; 
Stagl et al., 2015]. Existing guidelines highlight the importance of understanding the 
patients’ need of supportive care in relation to their individual perspectives [Adler & 
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Page, 2008; National Comprehensive Cancer Network, 2019]. This standard is widely 
accepted and is implemented in international guidelines. Moreover, it represents a 
criterion for fulfilling cancer center accreditation [Bultz et al., 2014; Pirl et al., 2014].  
2.1.2 Quality of life  
QoL has a different meaning for each individual. While one person derives the 
greatest satisfaction from spending time with his/her family and friends, another person 
thrives on traveling around the world. The World Health Organization (WHO) defined 
QoL as “an individual's perception of their position in life in the context of the culture 
and value systems in which they live and in relation to their goals, expectations, 
standards, and concerns. It is a broad ranging concept affected in a complex way by 
the person's physical health, psychological state, level of independence, social 
relationships, and their relationship to salient features of their environment” [World 
Health Organization, 1993]. Today’s medical opportunities help to save increasing 
numbers of cancer patients due to continuous advances in the clinical diagnostics and 
treatments. This advance has led to improved cure rates and longer survival times and 
goes along with having to deal with long-term side effects because of the toxicity of 
treatments. In recent years, the focus of cancer treatment has been increasingly shifted 
towards aspects of QoL, in addition to survival time. Recent reviews report evidence for 
a positive relationship between QoL and overall survival in cancer patients [Gotay et al., 
2008; Quinten et al., 2009]. In contrast, anxiety present in half of the cancer population 
is inevitably associated with diminished QoL [Stark et al., 2002].  
Besides prolonging survival time and managing treatment side effects, the 
individual perception of QoL has gained increasing importance in the past years. A 
recent article [Stickel & Goerling, 2018] provides an overview of the concept of QoL, 
emphasizing both its individuality and changeability with respect to cancer patients. The 
authors subsume the dependence of time and context and cite Aristoteles (384-322 BC) 
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“…and often the same person changes his mind: when he becomes ill, it is health, and 
as long as he is healthy it is money.” This shift in the subjective assessment of QoL is 
reflected in today’s clinical practice and must be taken into consideration when working 
with patients suffering from cancer. Moreover, surgery often leads to changes in 
physical perception and body image concerns [Avis et al., 2005; Fingeret et al., 2012]. 
Fatigue as a common early and chronic side effect of radiation therapy is reported in up 
to 80% of patients during radiation therapy and by 30% of patients at follow-up visits 
[Jereczek-Fossa et al., 2002]. Patients undergoing chemotherapy or combined 
radiotherapy-chemotherapy often suffer from fatigue on top of side effects such as 
nausea, vomiting, impacts on cognition, and pain [Carlson et al., 2004]. Fatigue is by 
far the most common symptom affecting QoL of cancer patients. Cancer-related fatigue 
is a “draining, ongoing exhaustion that limits one's ability to enjoy life and engage in 
activities” [National Comprehensive Cancer Network, 2003]. Moreover, fatigue may 
have implications for therapeutic decisions to interrupt the therapy or to decrease the 
dose. This in turn could influence the efficacy of the therapy. 
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2.2 Adjustment to cancer 
A cancer diagnosis leads to a long process of individual adaptation. Adjustment 
to a disease such as cancer “consists of the psychological processes by means of which 
the individual manages or copes with various demands or pressures” (p18. [Lazarus, 
1969]). Cognitive models of adjustment and coping assume that the interpretation of an 
(individual) stressful event determines the (individual) response to it [Folkman & Greer, 
2000; Lazarus & Folkman, 1984]. Receiving the diagnosis of cancer is a stressful event 
associated with concerns about the threats and course of disease as well as everyday 
problems of organizing daily life, often accompanied with confusion of thoughts and 
feelings. Certain patients might view their cancer diagnosis as a challenge and will feel 
empowered to master the consequences. In contrast, other patients might feel 
extremely threatened and restricted in their scope of action and access to resources. In 
extreme cases, affected patients will contemplate their immediate death. Thus, the 
range of reactions to the diagnosis of cancer is broad. Mehnert et al. reported a 4-week 
prevalence rate of 31.8% for any mental disorder, with the most common comorbid 
disorders being adjustment disorder (11%), anxiety disorder (11%), and mood disorder 
(11%) [Mehnert et al., 2014]. Symptoms such as fear of recurrence or demoralization, 
which many cancer patients are facing are often recognized [Herschbach, 2015].  
The model of Lazarus and Folkman [Lazarus & Folkman, 1984] describes two 
main appraisals of importance after an event. First, the model elucidates whether the 
event is perceived as stressful. The second question addresses the resources available 
to face the stressful event: “Do I have the resources to face it?” If patients answer the 
first question with “yes” and the second with “no”, they will presumably declare to be 
stressed, or they will achieve high scores on the validated distress thermometer (DT; 
[Mehnert et al., 2006] [National Comprehensive Cancer Network, 2019]). The model 
has been extended to include meaning-based coping (Folkman, 1997; Folkman & 
Greer, 2000). Thus, the first and second evaluation processes (primary and secondary 
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appraisals) have been supplemented by the individual search for meaning, by reflecting 
or modifying life goals and attempting to give the current (disease) situation a personal 
meaning.  
Social-cognitive transition (SCT; [Brennan, 2001] is an extension of the model of 
Lazarus and Folkman. Its conceptualization offers an inclusion of the experience of the 
social world and refers to the psychological adaption processes including personal 
growth as a reaction to a life event [Parkes, 1971]. It is an attempt to account for the 
huge diversity of experiences that people with cancer report, ranging from positive 
personal growth to psychological “disorders”. Although the clinical derivation of the 
model is conclusive, an exact measurement of these variables is still lacking. Measures 
of self-efficacy, control, and coping as well as individual perception of QoL might be 
used as congruent concepts [Brennan, 2001]. 
2.3 Psycho-oncological support 
In German-speaking countries, psycho-oncological care is mainly provided by 
psycho-oncology departments at the university hospitals (inpatient/outpatient) or 
cancer-counseling centers, e.g. the national cancer league (Krebsliga) in Switzerland 
or cancer aid (Krebshilfe) in Germany. In addition, psychologic/psychiatric private 
practices may provide outpatient services. 
Additionally, numerous rehabilitation clinics make an important contribution to 
psycho-oncological care [Mehnert & Hartung, 2015]. To identify patients with marked 
distress and a need for psycho-oncological support, standard screening tools such as 
the DT are widely used [Donovan et al., 2014; Mehnert et al., 2006; Mitchell, 2007]. 
These screening methods have the potential to remove barriers and facilitate access to 
psychosocial services. Nevertheless, the majority of newly diagnosed cancer patients 
lack psychosocial support due to constraints on both the providers’ and the patients’ 
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sides [Carlson, 2013; Carlson et al., 2004; Waller et al., 2013]. Consequently, measures 
and a better understanding of patients’ need of supportive care are needed.  
2.4 Psycho-oncological interventions  
Psychotherapeutic manuals to address stress management in general are well 
known (e.g. [Kaluza, 2004; Strobel, 2018]). There are two specific manuals addressing 
stress management in cancer patients [Antoni, 2003a, 2003b, 2003c; Moorey & Greer, 
2015]. Both manuals use the cognitive-behavior therapy (CBT) approach. Antoni 
developed a group intervention for women with breast cancer with the aim to increase 
personal awareness by psycho-education and the provision of coping strategies such 
as anxiety reduction and cognitive restructuration skills [Antoni, 2003a]. Morrey and 
Greer developed cognitive, behavioral, emotional, and interpersonal techniques to help 
people adjust to cancer in the challenging clinical environment of oncology and palliative 
care [Moorey & Greer, 2015]. A key aspect in the field of psycho-oncology is the concept 
of acceptance, which is “the willingness to accept the cancer and its effects as they are 
at the present moment and not to actively try to influence them” (p 79 [Geuenich, 2012]). 
Geuenich developed strategies to develop acceptance-enhancing skills. For her, 
acceptance of a cancer disease is the willingness to perceive the disease itself and its 
effects as existing [Geuenich, 2012]. The method is based on dialectic behavioral 
therapy (DBT, [Linehan, 2016]) and acceptance and commitment therapy (ACT; [Hayes 
et al., 1999]), both focusing on the concept of acceptance. DBT [Linehan, 2016] is based 
on CBT and places equal value on change and acceptance. This is of importance for 
the field of psycho-oncology because this theory supports the psychotherapeutic 
technique of confrontation with unpleasant feelings. People can only succeed if they 
perceive and accept their feelings and their triggers. Further, the term “double 
awareness” is used in the palliative context to describe a person’s capacity to engage 
in the world while preparing for their impending death. The acceptance and commitment 
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movement [Hayes et al., 1999] enriches the psycho-oncological field with skills to work 
with awareness and acceptance and supports cancer patients to cope with their fatal 
illness.  
Psychosocial support for cancer patients is effective in alleviating distress and 
improving QoL including fatigue, the most common complaint of cancer patients 
[Carlson et al., 2004; Duijts et al., 2011; Fors et al., 2011]. Randomized controlled 
studies have shown that psychosocial interventions have significant positive effects in 
cancer patients. Cognitive behavioral techniques support patients to develop 
appropriate coping strategies and reduce anxiety, depression, and distress levels thus 
improving QoL [David et al., 2013; Naumann et al., 2012; Osborn et al., 2006; Rehse & 
Pukrop, 2003]. For example, Duijts et al. concluded in their review that behavioral 
techniques significantly reduce cancer-related fatigue (d = -0.16), depression (d = -
0.336), and distress (d = -0.16) [Duijts et al., 2011]. Luebbert et al. found significant 
effects of relaxation techniques on emotional adjustment, depression (d = 0.54), and 
anxiety (d = 0.45) [Luebbert et al., 2001]. Zainal et al. demonstrated the effectiveness 
of mindfulness-based stress reduction (MBSR) in breast-cancer patients (stress 
reduction: d = 0.71, reduction of depression d = 0.58) [Zainal et al., 2013]. Moreover, 
psycho-oncological interventions may reduce side effects of cancer treatment [Antoni 
et al., 2009; Duijts et al., 2011; Kwekkeboom et al., 2012; Söllner & Keller, 2007; Wells 
et al., 2003]. For example, relaxation techniques have a small but significant effect on 
treatment-related symptoms such as pain (d = 0.43) and nausea (d = 0.45) [Luebbert 
et al., 2001].  
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2.5 Online psycho-oncological interventions 
The use of the internet1, which has become an integral part of all aspects of our 
lives, has the potential to provide more patients with psychosocial support. At least 70% 
of cancer patients use the internet as a source of information shortly after having been 
diagnosed [van de Poll-Franse & van Eenbergen, 2008]. Recent approaches of 
integrating the internet into the patient’s care concepts include the setup of patient 
forums and information sites as well as therapeutic games [Andersson, 2016; Kato et 
al., 2008]. Web-based interventions are usually implemented as self-guided or 
therapist-guided internet or cell phone-based programs, following a predefined structure 
with a given number of modules or exercises to be completed. Blended interventions 
are integrated combinations of face-to-face therapy together with an online program 
[Barak et al., 2009]. Internet programs based on cognitive behavioral techniques with 
patient guidance by regular online contact with a healthcare professional have emerged 
as being particularly effective. For a range of psychological disorders, including anxiety 
disorders and depression in non-cancer patients [Buntrock et al., 2016; Kessler et al., 
2009], therapist-guided online interventions seem similarly effective as face-to-face 
interventions [Andersson et al., 2014]. Online interventions offer advantages such as 
anonymity, which can be accompanied by increased openness or disinhibition [Suler, 
2000] and may extend the user spectrum to patients with a low threshold for support 
uptake. Moreover, the written exchange and asynchronous communication allow for a 
well-founded, reflective expression and flexibility in scheduling. In addition, the contents 
of the program can be accessed repeatedly. However, there are a number of limitations 
                                               
1 Note: In 2018, the American Medical Association (https://www.ama-assn.org/) proposed to 
use the lowercase for the term “internet“ due to its frequent use.  
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of this form of support. Online interventions are not suitable in an acute psychosocial 
crisis with suicidal tendencies or disorders that require immediate therapeutic action. 
Barriers to use online intervention are lack of basic computer skills or lack of access to 
an online device, as well as missing possibilities for written exchange. [Knaevelsrud et 
al., 2004]. A detailed overview of advantages and disadvantages of online therapy can 
be found in a recent publication [Schuster et al., 2018]. 
The success of web-based guided self-help tools in psychological disorders 
[Andersson, 2016; Andersson et al., 2014] has boosted our interest in online 
interventions in oncology. Such psychosocial tools are of particular merit to cancer 
patients living in rural areas or places far away from large cancer centers [Carlson et 
al., 2004]. Numerous piloted and on-going trials in cancer patients seek to define 
suitable indications, formats, and settings [Beatty et al., 2016]. The few larger 
randomized, controlled trials published so far [Carpenter et al., 2014; Hummel et al., 
2017; van den Berg et al., 2015] show encouraging results with improvement in a 
number of relevant psychosocial domains, including coping with cancer [Carpenter et 
al., 2014], sexual functioning [Hummel et al., 2017], and distress [van den Berg et al., 
2015] in breast cancer survivors.  
2.5.1 User-friendliness of web-based interventions 
User-friendliness often determines whether a website or internet program is used 
by the intended population [Gorlick et al., 2014]. The few existing guidelines (e.g. 
[Leykin et al., 2012] stress the importance of conducting formalized usability testing of 
web-based healthcare interventions in the target population to assess whether the end-
user can work with the webpage during specific tasks. Usability is defined as “the extent 
to which a product can be used by specified users to achieve specified goals with 
effectiveness, efficiency, and satisfaction in a specified context of use’’ (ISO 9241-11 
[International Standardization Organization, 1998]). In formalized usability testing, the 
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observed usability problems are grouped to identify flaws within the system, ultimately 
leading to design improvements that remove these barriers [International 
Standardization Organization, 1998; Tullis & Albert, 2013]. Appropriately designed 
online tools can augment dissemination of psychosocial care by making participation 
convenient, confidential, and less stigmatizing [Leykin et al., 2012; Owen et al., 2004]. 
Nevertheless, high dropout rates [Baltanas et al., 2013; David et al., 2013] and low 
levels of commitment have been reported for some web-based interventions [Gorlick et 
al., 2014]. 
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2.6 Objectives 
Although distress-screening programs aim to ensure appropriate psycho-
oncological support, cancer patients often do not use such services. We aimed to 
understand the acceptance and reasons of acceptance of psycho-oncological support. 
The investigation of the first web-based stress management intervention 
STREAM for newly diagnosed cancer patients forms the main part of this thesis. The 
rationale for this early intervention was three-fold: First, distress in patients with cancer 
peaks shortly after the diagnosis [Fang et al., 2012], irrespective of the cancer type. 
Second, the period immediately after the diagnosis tends to be busy with diagnostic and 
therapeutic appointments. Therefore, self-management of time, location, and autonomy 
made possible by web-based interventions might be of particular value to these patients 
[Andersson, 2016]. Third, successful early psychosocial interventions have shown a 
substantial potential to affect the course of the disease beyond psychosocial outcomes 
[Temel et al., 2010]. We conducted a preparative usability testing with the aim to adjust 
the final website to the specific use by our target population. Usability testing of the tool 
was followed by the prospective randomized wait-list controlled trial to assess the 
following:  
§ Feasibility including patient’s characteristics, patient’s adherence, dropout rate, 
therapeutic alliance as well as the time required for psycho-oncological support. 
§ Efficacy of the intervention with respect to improved QoL and mood and lowered 
distress in newly diagnosed cancer patients.  
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3. Methods 
3.1 Research projects  
As outlined above, this thesis is based on two projects linked by contents in the 
same target population. My focus was the development of STREAM and its testing in 
the randomized, controlled trial entitled “Web-based stress management for newly 
diagnosed cancer patients (STREAM-1): a randomized, wait-list controlled intervention 
study” with the subproject “Usability testing of a newly developed stress management 
website for cancer patients” which was part of the development procedure. 
Furthermore, during my clinical work as psycho-oncologist at the Department of Medical 
Oncology at the University Hospital Basel, I contributed to the project “Understanding 
why cancer patients accept or turn down psycho-oncological support: A prospective 
observational study including patients’ and clinicians’ perspectives on communication 
about distress”. 
The following section summarizes the methodology of each project. These 
projects influenced each other by transferring the findings from clinic to science, and 
vice versa. Because of the focus of the various studies, the sequence of their description 
is as follows: acceptance psycho-oncological support, usability testing of STREAM, as 
well as feasibility and efficacy testing of STREAM. 
3.1.1 Acceptance of psycho-oncological support 
For support options to be effective, the specific needs and limitations of the 
intended population have to be known. We analyzed the willingness of cancer patients 
to accept psycho-oncological support as part of the project entitled “Understanding why 
cancer patients accept or turn down psycho-oncological support: A prospective 
observational study including patients’ and clinicians’ perspectives on communication 
about distress” [Zwahlen et al., 2017]. This study was approved by the local ethics 
committee (EKNZ 220/13) and was funded by the Swiss Cancer League (Grant No. 
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KLS 3186–02-2013). The study took place at the oncology outpatient clinic of the 
University Hospital Basel, Switzerland.  
We conducted a prospective, observational study in a Swiss oncology outpatient 
clinic and assessed distress, intention to use psycho-oncological support, and use of 
the psycho-oncology service by using the DT, a semi-structured interview, and hospital 
records. Our population included cancer outpatients who presented at the outpatient 
clinic for the first time. Patients were eligible when fulfilling the following inclusion 
criteria: aged ≥18 years, fluent in German, not being physically or cognitively impaired 
in a way that impeded study participation, and having at least one further consultation 
planned with an oncologist. We analyzed the data with a mixed-methods approach. 
Details of this analysis are described below in section 4. The detailed method of the 
entire trial is described elsewhere [Zwahlen et al., 2017]. 
3.1.2 Usability testing of STREAM 
To ensure that online health interventions meet the needs of cancer patients and 
is accepted by them, structured usability testing to identify usability issues should be 
addressed early during development of a new program. For the preparation of the 
subsequent trial STREAM, the usability trial called “Usability testing of a newly 
developed stress management website for cancer patients” was conducted in 
cooperation with the computer laboratory of the Center of Human-Computer Interaction 
of the Department of Psychology at the University of Basel. The local ethics committee 
(EKBB) approved the trial (EKBB 251/13)2. The Swiss National Science Foundation 
(Grant No. PP00P3_139155/1 awarded to Viviane Hess; Grant No. PP00P1_144824 
                                               
2 Note: Between the two projects (usability trial and the main STREAM trial), EKBB was 
renamed to Northwest and Central Swiss Ethics Committee (EKNZ). 
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awarded to Thomas Berger), and Swiss Cancer Research (Grant No. KFS-3260-08-
2013 awarded to Corinne Urech) supported this study. Usability of a newly developed 
online stress management program was prospectively assessed in patients with solid 
tumors undergoing systemic treatment.  
In an academic computer laboratory of the University of Basel, each patient 
completed 16 tasks concerning the key components of the program, e.g. website 
navigation, login-in to secure area, completing forms, accessing audio files, and 
contacting the trial team. Usability problems during these tasks were identified via the 
think-aloud method. This method encourages patients to think aloud while solving a 
problem, thereby giving observers an insight into the participant's cognitive processes. 
General usability was tested with the system usability scale (SUS). The usability testing 
process and key aspects of online intervention tools for the final version of STREAM 
are presented below. 
3.1.3 Feasibility and efficacy testing of STREAM  
The research project was entitled “Web-based stress management for newly 
diagnosed cancer patients (STREAM-1): a randomized, wait-list controlled intervention 
study”. The local Ethics Committee approved the study (EKNZ 339/13). The Swiss 
National Science Foundation (SNSF PP00P3_139155/1) and Swiss Cancer Research 
(KFS-3260- 08-2013) supported this study financially.  
In this prospective, randomized, controlled intervention study (Figure 1), patients 
were randomized 1:1 (mixed randomization scheme using unequal block 
randomization) to either the intervention group or wait-list control group. Patients were 
stratified according to their baseline stress level (DT ≥5 vs <5; [Mehnert et al., 2006]). 
A total of 129 newly diagnosed adult (>18 years) cancer patients who had started first-
line systemic treatment (including chemotherapy, hormonal treatment, or targeted 
therapy) or radiotherapy not longer than 12 weeks before were included after giving 
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informed consent. Patients who underwent treatment for a first relapse of a tumor 
previously treated with curative intent were also eligible. Patients were required to read 
and write in German, have internet access, as well as basic computer skills. 
Assessment took place at three time points (see Figure 1). The intervention consisted 
of eight modules with weekly written feedback by a psychologist (“minimal contact”) 
based on well-established stress management manuals including downloadable audio-
files and exercises. 
 
 
Figure 1. Study design: Web-based stress management for newly diagnosed cancer patients (STREAM-
1): a randomized, wait-list controlled intervention study, published in [Grossert et al., 2016]. 
 
The aim of this study was to evaluate efficacy in terms of improvement in QoL as 
well as decrease in anxiety and depression, as compared to patients in the wait-list 
control group. All analyses were done for the intention-to-treat (ITT) population defined 
as all patients who underwent randomization. The per-protocol (PP) population included 
all patients who completed the program in the intended time frame, i.e. a maximum of 
16 weeks between the time of randomization and T2 assessment which was twice the 
minimal duration of the program.  
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To demonstrate a 9-point difference [Naumann et al., 2012] in the ‘Functional 
Assessment of Chronic Illness Therapy–Fatigue’ (FACIT-F) questionnaire total score 
between baseline and T2 (after 8 weeks) in the intervention group with a statistical 
power of 0.80 at a significance level of 0.05 (two-sided), 60 participants were required 
per group. Minimal ‘clinically meaningful differences’ are not well defined but have 
previously been set between 7 and 9 points, both as intra-individual changes and 
differences between groups [Cella et al., 2002; Temel et al., 2010]. Secondary 
endpoints included distress measured with the DT [Mehnert et al., 2006] and 
anxiety/depression measured with the Hospital Anxiety and Depression Scale (HADS; 
[Zigmond & Snaith, 1983]. Efficacy outcomes were modeled with analysis of covariance 
(ANCOVA), using the post-intervention score (T2) as dependent variable, the pre-score 
(T1) as covariate, and group allocation (intervention vs control) as independent 
variables. ANCOVAs were further adjusted for the stratification factor ‘distress’ (DT ≥5 
vs <5). To assess the robustness of the results, sensitivity analyses were conducted for 
all outcomes in the PP population. For further details of the trial see study protocol 
[Grossert et al., 2016] in the appendix. The results were published in the Journal of 
Clinical Oncology [Grossert et al., 2018] and are presented in section 4. 
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3.2 STREAM  
This section outlines the contents of the eight-week program, focusing on the 
topics covered in each part. We intended to develop a program for patients in the early 
phase of disease that diminishes their distress caused by the diagnosis and symptoms 
of their illness. 
3.2.1 Structure 
STREAM is an eight-module program covering the following sections: 1) overall 
introduction to stress; 2-4) specific nature of stress and coping with it on levels of the 
body, cognition, and emotions; 5) mindfulness and acceptance of thoughts and 
emotions; 6-7) activation of resources, and 8) summary. Table 1 provides an overview 
of the content and structure. Five icons guide the participants through the modules as 
well as the entire program (see Figure 2). The program is a guided intervention tool, 
which implies that guidance is provided page-by-page and module by module. Every 
edited page will remain accessible and visible during completion of the program. Each 
module should be completed in 60 to 90 min. Participants are asked to complete one 
module per week. Thus, completion of the full program takes eight weeks in total.  
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Module  Psychoeducation  Reflection on 
status 
Strategies 
1.  Introduction:  
What is stress?  
Nature of stress in 
general and in 
specific cancer 
related situations 
My individual 
stressor  
Stress protocol 
Diaryb 
Body scana 
Stress protocol b 
2.  Body stress 
reduction 
Bodily sensations 
during stress and 
side-effects of 
anticancer treatment 
Relaxation 
protocol 
Progressive Muscle 
Relaxation a 
Strand promenadea 
Relaxation protocolb 
3.  Cognitive stress 
reduction 
Thoughts and their 
interaction with 
emotions and bodily 
sensations 
My negative 
thought patterns 
Negative thought 
cyclea 
Relationship of body 
position and 
thoughtsb 
Thinking styles and 
reflextionb 
Thoughts on cloudsa 
4.  Emotional stress 
reduction 
Feelings and cancer-
related emotions as 
anxiety and worries 
were explained 
My feelings and 
worries 
Mountain meditationa 
Emotional 
emergency kita 
5.  Mindfulness and 
acceptance of 
thoughts and 
emotions 
Meaning of 
mindfulness and 
acceptance and their 
implementation in 
daily life in contrast to 
the active strategies 
learned in modules 1-
4 
My definition and 
experiences with 
acceptance 
Acceptance story a,b 
Body scana,b 
Integration of 
mindfulnessb 
Winter walka 
Awakening springa 
6.  Activation of 
resources:  
quality of life and 
pleasure 
Introduction of 
models of the 
balance between 
burden and 
resources  
 
My individual 
resources 
Health-cycle b 
Planning activitiesb 
Week planner b 
Friendly feelings with 
our own bodya 
Enjoyment trainingb 
7.  Activation of 
resources:  
social network 
and 
communication 
skills 
Social network and 
the role of a 
supportive 
environment 
My individual 
social network 
and current 
needs 
Communication 
skillsb 
Strand promenadea 
Winter promenadea 
Awakening springa 
8.  Summary Concluding an 
overview and 
documentation of the 
last 7 weeks 
My experiences 
with the program 
Four seasonsa 
 
Table 1. Content of the web-based stress management program STREAM  
a) Audio file: story, relaxation, or guided imaginary exercise, b) Instructions and worksheets 
 
 
37 
 
Figure 2. Welcome page of module 1, concerning the topic “What is stress”. The five icons (information; 
reading and understanding; observing and recognition; testing and experiencing; evaluation) navigate the 
user as required. 
At the beginning of every module, distress level and actual motivation to work on 
the program is evaluated. Then, the specific contents are introduced, starting with a 
short mindfulness breathing exercise. The specific contents include (a) text-based 
psycho-education, (b) reflection on the current individual emotional status, and (c) 
acquisition of strategies including exercises. Within each module, exercises with 
respect to relaxation techniques and guided-imagery exercises are available as audio 
files that can be downloaded to various devices (e.g., PC/Mac, tablets, smart phones, 
MP3 players). Patients are encouraged to use the audio files daily. The final page of 
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each module evaluates the anticipated therapeutic benefit and criteria of usability of the 
website.  
3.2.2 Content  
The STREAM program is based on well-described and established stress 
management intervention manuals [Angenendt et al., 2007; Antoni, 2003a; Geuenich, 
2012; Kaluza, 2004; Weis et al., 2006], which we adapted to the participants’ situation 
of suffering from cancer and its treatment as well as to the instrument’s use as a web 
tool. The program primarily aims to improve intra- and interpersonal coping strategies 
to enhance QoL and reduce the distress perceived by newly diagnosed cancer patients. 
The breathing exercises suggested to the users before starting to work on the modules 
were specifically designed to help the patient focus on a new topic. The following 
paragraphs detail the contents of each module. 
1. Overall introduction: This module focuses on the introduction and psycho-
education of the nature of stress in general and cancer-related situations in particular. 
Patients are made aware of their individual stressors and the specific stress reaction to 
this severe disease. Apart from suggesting a breathing exercise, the module teaches a 
first relaxation technique and encourages participants to write a diary focusing on their 
daily stressors and emotions.  
2. Body stress reduction: The reaction to stressful events of the body is 
addressed, and participants are encouraged to reflect on their individual perception. 
Information on side effects of the therapy and coping strategies are provided. Relaxation 
techniques such as visual imagery, progressive muscle relaxation, and mindfulness-
based exercises are introduced. 
3. Cognitive stress reduction: The cognitive model of adjustment and coping 
[Lazarus & Folkman, 1984] when faced with cancer are presented. Again, the focus is 
on detecting and identifying one’s own helpful and unhelpful cognitive patters (e.g. all-
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or-nothing thinking, selective abstractions, over-generalization). Exercises are provided 
to work on these unhelpful patterns and “stressful” thoughts. In this module, participants 
detect their automatic thinking in connection with their illness and learn to identify their 
negative thoughts. Strategies to provide alterative thought options in response to such 
automatic thinking are provided. 
4. Emotional stress reduction: This module covers the emotional reaction to the 
disease and treatment by analyzing individual emotions and identifying strategies to 
cope with strong emotions. 
5. Mindfulness and acceptance of thoughts and emotions: This module presents 
a more meaningful and acceptance-based approach as an additional coping strategy. 
Participants are encouraged to implement these strategies in their daily lives. In 
addition, patients learn how changes in their attitude can be helpful for coping with life 
under the new condition. 
6. Activation of resources: QoL and pleasure: Some patients experience a 
complete change of their lives after their cancer diagnosis. Therefore, this module 
focuses on re-activating previous resources or developing new resources to improve 
their QoL. Exercises help patients to identify the most effective source of power at the 
moment and how to incorporate them in their everyday life in combination with weekly 
activity scheduling.  
7. Activation of resources: Social network and communication skills: This module 
focuses on resources in connection with the patient’s social network. The patient’s 
disease affects not only his/her own life but tends to impact on the entire social network. 
Patients and their relatives and friends may have difficulty in communicating about the 
illness and its impact. This module introduces various communication strategies and 
suggests methods to cope with a deficient or absent social network.  
8. Summary: This module provides an overview of the previous seven modules 
and encourages patients to reflect on their individual thought processes. 
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3.2.3. Minimal contact 
As the program is a minimal-contact tool, the responsible therapist is due to 
respond by secure integrated e-mail after the participant has completed a module, i.e. 
after one week. Patients can use the secure chat function to contact the psychologist at 
any time, and an answer is provided within three working days. The underlying 
therapeutic attitude is based on a humanistic approach, with the therapist being 
empathetic and appreciative of the patient's problems with the ultimate aim to support 
the patient’s self-efficacy. This semi-structured contact includes four sections: 
a) appreciation, b) understanding, c) embedding, supporting, and facilitating, and 
b) closing (see Table 1 for module contents). In case of persisting problems (e.g. 
suicidal ideation), clear recommendation for further assistance (e.g. face-to-face 
therapeutic support, psychiatric emergency care) is provided. Supervision and 
intervision of the therapists are conducted on a weekly basis.  
3.2.4 Technical realization 
The use of web-based healthcare interventions is growing rapidly, enabling 
certain aspects of mental healthcare to be delivered directly to the patient without face-
to-face interactions. To develop a user-friendly program, we cooperated with the 
professional software engineering company YooApplication (Basel, Switzerland). The 
webpage was developed individual on the basis of Microsoft .NET Frameworks 4.5. The 
application is divided into a public, an user area and a back-end area for supervision 
and support. In the public area, information regarding the STREAM program and trial 
was presented3. Potentially interested participants were able to register using a digital 
contact form generating an e-mail to an official email account of the University Hospital 
                                               
3 www.stress-aktiv-mindern.ch [STREAM, 2016] 
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of Basel (stream@usb.ch). This warranted secure data transfer using the Health Info 
Net (HIN) system from the provider side. Due to the confidential personal data, eligibility 
and assessment of the potentially interested persons took place outside the platform 
[Grossert et al., 2016]. After enrollment and group allocation participants got 
automatically generated login data and password for the user area4. On each internet 
page, the Secure Socket Layer (SSL) cryptographic technique with its own certificate 
warranted secure data transfer. At the back-end area for supervision and support, the 
responsible psychologist had read-only access to module progress and could write 
individual feedback.  
Furthermore, the company VIZUAL Graphic&Code (Luzern, Switzerland) for the 
logo development (Figure 3) and Typo.d (Reinach, Switzerland) for design development 
professionally supported the visual appearance.  
 
 
 
Figure 3. Logo.  
                                               
4 For an inside into the program STREAM see section videos on http://www.stress-aktiv-
mindern.ch/Medien [STREAM, 2016] 
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4. Summary of results - Publications 
4.1 Focusing on cancer patients’ intention to use psycho-oncological support:  
a longitudinal, mixed-methods study 
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Objective: Distress screening programs aim to ensure appropriate
psychooncological support for cancer patients, but many eligible patients do not use
these services. To improve distress management, we need to better understand
patients' supportive care needs. In this paper, we report the first key finding from a
longitudinal study that focused on patients' intentions to use psychooncological sup-
port and its association with distress and uptake of the psychooncology service.
Methods: We conducted a prospective, observational study in an Oncology
Outpatient Clinic and assessed distress, intention to use psychooncological support,
and uptake of the psychooncology service by using the Distress Thermometer, a
semistructured interview, and hospital records. We analyzed data with a mixed‐
methods approach.
Results: Of 333 patients (mean age 61 years; 55% male; 54% Distress Thermome-
ter ≥ 5), 25% intended to use the psychooncology service (yes), 33% were ambivalent
(maybe), and 42% reported no intention (no). Overall, 23% had attended the
psychooncology service 4 months later. Ambivalent patients reported higher distress
than patients with no intention (odds ratio = 1.18, 95% confidence interval [1.06‐
1.32]) but showed significantly lower uptake behavior than patients with an intention
(odds ratio = 14.04, 95% confidence interval [6.74‐29.24]). Qualitative analyses
revealed that ambivalent patients (maybe) emphasized fears and uncertainties, while
patients with clear intentions (yes/no) emphasized knowledge, attitudes, and coping
concepts.
Conclusions: We identified a vulnerable group of ambivalent patients with high distress
levels and low uptake behavior. To optimize distress screening programs, we suggest
addressing and discussing patients' supportive care needs in routine clinical practice.
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TONDORF ET AL. 16571 | BACKGROUND
Cancer patients with untreated, high levels of psychosocial distress
are at risk for nonadherence to cancer treatment,1 reduced quality
of life,2 and comorbid mental disorders.3-6 Psychooncological inter-
ventions can effectively reduce distress,7 but many eligible patients
do not take advantage of support services.8,9 A third of all cancer
patients show clinically significant levels of psychosocial distress,3
but more than half of them do not want psychooncological support
(42‐75%),10-15 although many patients with less distress do want
support (10‐44%).11,15-17 Even patients who want and are offered
psychooncological support do not always use these services.18
Guidelines highlight the need to understand patients' supportive care
needs to remove barriers and facilitate access to psychosocial
services.8,18-20
Salmon et al20 referring to Jonathan Bradshaw21 recently brought
patients' supportive care needs into focus by acknowledging that
there is not only a normative need for support (defined by experts),
indicated by an elevated distress score on the Distress Thermometer
(DT) or other screening instruments, but also a felt need for support
like a wish or desire that can become an expressed need for support,
indicated, for example, by an expression of clear intent to use the
known and available psychooncology service. Previous studies exam-
ined why a cancer patient's distress level did not always conform to
their wish for support or adherence to services.10,17,18,22-25 Most stud-
ies have focused on patients with high distress levels, and few used
qualitative methods to understand patients' needs.26,27
We took an inductive, qualitative approach to understanding
patients' supportive care needs without dividing them a priori into
low‐ and high‐distress groups. Our longitudinal mixed‐methods design
supplemented qualitative analysis with quantitative assessment of dis-
tress and uptake of the outpatient psychooncology service in a longi-
tudinal mixed‐methods design. We formulated 3 research questions:
(1) What proportion of cancer patients intends, maybe intends, and
does not intend to use the psychooncology service? (2) How are
patients' intentions associated with distress and uptake of service?
(3) Why do patients intend, maybe intend, and not intend to use the
psychooncology service?2 | METHODS
We report findings from a prospective, observational study in the
Oncology Outpatient Clinic of the University Hospital Basel (Switzer-
land). Our methods are briefly outlined below; we have described
them in more detail elsewhere.282.1 | Participants
Cancer outpatients who presented for the first time and used the out-
patient oncological care at the clinic were eligible when fulfilling the
inclusion criteria: ≥18 years, fluent in German, not being physically
or cognitively impaired in a way that impedes study participation,
and having at least 1 further consultation planned with an oncologist.2.2 | Standard screening and referral procedure
Based on a stepped‐care model,19 patients were routinely screened
with the DT at their first outpatient consultation for psychosocial dis-
tress. A nurse asked patients to fill in the DT, which patients then
handed to the oncologist. All patients were given written information
about the outpatient psychooncology service. The service is available
for free and on short notice for all outpatients. Oncologists were
briefed to address psychosocial distress during the first consultation
and to recommend the service to patients, based on a clinically rele-
vant distress level (DT ≥ 5), their clinical judgment, or the patient's
wish.2.3 | Study procedure
Oncologists screened cancer patients for interest to participate. The
study team informed interested patients about the study, obtained
informed consent, and interviewed participants an average of 15 days
after the first consultation. Semistructured interviews were conducted
in German and over the phone or face‐to‐face. Interviewers (TT and 7
Master's level students) relied on a manual. They were trained to use
comprehension questions, reflection, and summaries to clarify mutual
understanding; to take notes on participants' answers to open‐ended
questions during the interview, verbatim if possible; and to make
postscripts of the interviews immediately afterward.29 This study
complied with the Declaration of Helsinki. The local ethics committee
approved the study (Ethikkommission Nordwest‐und Zentralschweiz,
ref. no.: EK220/13).2.4 | Measures
2.4.1 | Sociodemographic and clinical characteristics
Patients' sociodemographic data were recorded during the interview.
Clinical data were collected from patients' medical records.2.4.2 | Psychosocial distress screening
We used the German version of the National Comprehensive Cancer
Network DT to assess self‐reported psychosocial distress on a visual
analogue scale from 0 to 10.30 The 1‐item screening tool shows good
reliability and validity and has a cutoff value of ≥5 for clinically signif-
icant levels of psychosocial distress (from 0 “no distress” to 10
“extreme distress”).302.4.3 | Intention and reasons for uptake of
psychooncological support
We asked the participants about their prospective intention during the
interview: “Do you intend to uptake the outpatient psycho‐oncologi-
cal support service in the next months?” The interviewer categorized
the participants' responses into 3 answers (yes/maybe/no), followed
by an open‐ended question: “What are the reasons why you do
[may/not] intend to use the outpatient psycho‐oncological support
service?”
TABLE 1 Participants' sociodemographic and clinical characteristics
Participants (n = 333), Unless Otherwise Stated n %
Age, in Years
Mean (SD) 60.5 (14.0)
Range 19‐93
Sex
Female 151 45.3
Male 182 54.7
Education
Low (9th grade or less) 31 9.3
Middle (apprenticeship/high school) 186 55.9
High (diploma/university degree) 116 34.8
Living with a partner
Yes 233 70.0
No 100 30.0
Living with children
Yes 72 21.6
No 261 78.4
Distress thermometera
DT score 0‐4 132 46.5
DT score 5‐10 152 53.5
Time after initial cancer diagnosis, in weeks
Median (range) 4 (0‐264)
Cancer typeb
Breast cancer 67 20.1
Thoracic malignancies 59 17.7
Hematologic malignancies 51 15.3
Genitourinary cancer 28 8.4
Melanoma/skin cancer 27 8.1
Gastrointestinal (noncolorectal) cancer 22 6.6
Central nervous system tumors 16 4.8
Others 64 19.2
Treatment approach
Palliative 128 38.4
Curative 205 61.6
Current treatments (multiple treatments possible)
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service
We defined uptake as having attended at least one appointment at the
outpatient psychooncology service within 4 months after study entry
and retrieved this information from hospital records.
2.5 | Data analyses
2.5.1 | Quantitative analyses
We conducted descriptive analyses for sociodemographic and clinical
data. To determine the association between a priori selected
sociodemographic variables, which are known to predict the use of
psychological support, distress, and intention, we performed a multi-
nomial logistic regression analysis. To determine the association
between intention and uptake, we performed a logistic regression
analysis. Results were presented as odds ratios with 95% confidence
intervals. The level of significance was set at P < .05. Analyses were
conducted by using SPSS Statistics version 22.0 (IBM, Armonk/NY,
2013).
2.5.2 | Qualitative analyses
We used content analysis to examine reasons for uptake of the
psychooncology service.31 This standardized, inductive approach ana-
lyzes qualitative data descriptively, adding a level of interpretation.32
To guarantee high‐quality content analyses, a team of trained
researchers (AG, DZ, and TT) discussed the patients' reasons in a mul-
tistep procedure. First, we read the answers of the patients several
times, divided the participants' answers into single reasons, and col-
lected ideas about categories. Second, we gathered categories in a
sample of 60 patients and refined them through an iterative process.
Third, we coded reasons of all patients into categories, discussed
inconsistence of assignment until consensus was reached, and
assessed interrater‐ reliability by using Cohen kappa statistics (κ).
Additionally, we identified main themes across categories. Analyses
were conducted by using MAXQDA software version 12.2.0 (VERBI
Software, Berlin, 2016).Systemic treatmentc 298 89.5
Radiotherapy 109 32.7
Surgery 34 10.2
No treatment/watch‐and‐wait/others 21 6.3
Abbreviations: SD, standard deviation; DT, Distress Thermometer.
an = 284, DT from n = 49 patients missing due to nondelivery of the DT by
clinical staff (n = 18), not being provided by patients (n = 22), and lost doc-
uments (n = 9).
bOne participant with 2 cancer types.
cSystemic treatment includes chemotherapy, immunotherapy, hormone
therapy, and targeted therapy.3 | RESULTS
3.1 | Participant characteristics
Of 1240 outpatients who attended the clinic during 2013 to 2016 for
an outpatient consultation, 484 were ineligible because of no further
consultation, not being fluent in German, or being physically or cogni-
tively impaired. Of all patients who attended the clinic, 756 (61%)
were eligible for inclusion (Figure S1). In total, n = 333 patients com-
pleted the study (Table 1).
3.2 | Distress, intention, and uptake of the
psychooncology service
Of all participants, 53.5% showed high levels of psychosocial distress
(DT ≥ 5); distress was normally distributed among all participants.
Overall, 83 patients (25%) intended to use the psychooncology service
(yes), 111 patients (33%) were ambivalent (maybe), and 139 patients(42%) did not intend to use the service (no). We found high distress
scores (DT ≥ 5) in 71% of patients with yes, 56% of patients with
maybe, and 42% of patients with no intention. After 4 months, 77
patients (23%) had used the service at least once (54 with yes inten-
tion [65% of all yes], 13 with maybe intention [12% of all maybe],
and 10 with no intention [7% of all no]). Figure 1 shows distributions
of uptake stratified according to levels of distress and intentions.
Answer n (%) Answer n (%)
Low Distress
DT<5 n=132
Yes 20 (15.2) Yes 12 (60.0)
No 8 (40.0)
Maybe 39 (29.5) Yes 2 (5.1)No 37 (94.9)
No 73 (55.3) Yes 3 (4.1)No 70 (95.9)
High Distress
DT 5 n=152
Yes 50 (32.9) Yes 33 (66.0)No 17 (34.0)
Maybe 49 (32.2)
Yes 7 (14.3)
No 42 (85.7)
No 53 (34.9) Yes 6 (11.3)No 47 (88.7)
Distress UptakeIntention
T0; first consultation T1; 2 weeks after T0 T2; 16 weeks after T0 t
FIGURE 1 Description of patients' distress, intention, and uptake by distress level. Abbreviations: DT, Distress Thermometer; T0, screening; T1,
baseline; T2, follow‐up
TONDORF ET AL. 1659In a multinomial logistic regression, patients with yes intention
and patients with maybe intention were significantly more distressed
than patients with no intention (yes: mean = 5.8 [SD = 2.4]; maybe:
mean = 5.0 [SD = 2.6]; no: mean = 3.9 [SD = 2.7]). Age, sex, and edu-
cation did not differ between intention groups (Table 2A). In a logistic
regression analysis, patients with maybe and no intention showed sig-
nificantly lower uptake behavior than patients with yes intentionTABLE 2 Associations among sociodemographic variables, distress, and i
(A) Multinomial Regression Analysis of Sociodemographic Variables and Dist
Intention Yes vs Noa Intentio
B (SE) OR [95% CI] P Value B (SE)
Distress (DT 0‐10) 0.28 (0.06) 1.32 [1.17‐1.49] <.001** 0.17 (0
Age −0.02 (0.01) 0.98 [0.96‐1.00] .107 −0.01 (0
Sex (0 = male, 1 = female) 0.19 (0.32) 1.21 [0.65‐2.24] .553 0.20 (0
Education (0 = low,
1 = high)
−0.14 (0.33) 0.87 [0.46‐1.66] .672 −0.11 (0
(B) Logistic regression analysis of intention on uptake
B (SE)
Intention yes vs noa 3.18 (0.40)
Intention maybe vs noa 0.54 (0.44)
Intention yes vs maybeb 2.64 (0.37)
Note. (A) Model χ2 (8) = 28.94, P < .001, n = 284, Nagelkerke R2 = 0.110. Educ
ticeship/high school) and “high” (diploma/university degree). (B) Model χ2 (2) =
Abbreviations: B, Beta coefficient; SE, standard error; OR, odds ratio; CI, confid
aReference group no intention.
bReference group maybe intention.
*P < .05.
**P < .001.(Table 2B). This result did not materially change after adjustment for
sociodemographic variables (data not shown).3.3 | Reasons for yes, maybe, or no intention
Patients gave a total of 734 reasons, averaging 2.2 reasons per patient
(min. 1, max. 6 reasons). Content analysis identified 32 categories ofntention as well as intention and uptake
ress on Intention
n Maybe vs Noa Intention Yes vs Maybeb
OR [95% CI] P Value B (SE) OR [95% CI] P Value
.06) 1.18 [1.06‐1.32] .003* 0.11 (0.06) 1.12 [0.99‐1.26] .078
.01) 0.99 [0.97‐1.01] .406 −0.01 (0.01) 0.99 [0.97‐1.01] .410
.29) 1.22 [0.69‐2.14] .497 −0.01 (0.33) 0.99 [0.52‐1.88] .980
.30) 0.90 [0.50‐1.62] .722 −0.03 (0.34) 0.97 [0.50‐1.88] .924
OR [95% CI] P Value
24.02 [10.95‐52.71] <.001**
1.71 [0.72‐4.07] .22
14.04 [6.74‐29.24] <.001**
ation was dichotomized into “low/medium” (less than ninth grade/appren-
100.66, P < .001, n = 333, Nagelkerke R2 = 0.395.
ence interval; P value, significance level; DT, Distress Thermometer.
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TONDORF ET AL. 1661patients' reasons and 4 main themes. Interrater reliability was strong
to moderate (κ = 0.70‐0.89).33 Table S1 contains a detailed description
of all categories and number of reasons per group.
Four main themes emerged across groups: attitude (ATT), coping
(COP), distress (DIS), and support (SUP). Attitude includes categories
that describe patients' opinions about psychooncological support.
Coping includes different strategies that patients say they used to han-
dle a situation. Distress consists of several categories that describe
either subjective distress or well‐being as a reason for uptake or
decline of support. Formal and informal support includes categories
that describe support needs of patients.
Patients with a yes intention wanted to consult psychooncologists
mainly because (1) they considered the psychooncologists to be expe-
rienced experts [ATT1], (2) they wanted support for self‐empower-
ment [COP1], and (3) they wanted to prepare for potential physical
or mental deterioration [DIS1]. Patients with no intention generally
(1) felt supported enough by family and friends [SUP2], (2) reported
mental and physical well‐being [DIS8], and (3) did not think psycholog-
ical support would be helpful [ATT9]. Ambivalent patients (maybe)
combined reasons for and against support, and they often described
a potential situation in which they would consider taking advantage
of support services (ie, if‐then thinking): (1) They wanted to use sup-
port if their physical or mental condition deteriorated [DIS1], (2) they
currently felt supported enough [SUP2], and (3) they felt physically
and emotionally well [DIS8]. Other reasons are listed in order of rank
in Table 3 and Table S1.4 | DISCUSSION
To the best of our knowledge, this study is the first longitudinal,
observational study with prospective data along the distress screening
pathway assessing cancer patients' distress, intention, and uptake of
the psychooncology service focusing on patients' intentions by using
mixed methods.
Our study had 3 key findings. First, with a trichotomous assess-
ment of health‐care service needs (yes/maybe/no), we identified a
considerable number of ambivalent patients (33%), who had high
mean distress levels but were less likely to use services. Second,
we found an association between level of distress and patients'
intentions, but 67% of patients with a high distress level did not
intend to use support immediately. Third, qualitative analyses
revealed different motives of ambivalent patients and patients with
no or yes intention.
In line with previous research,13,15,22,34 we found that the level of
distress, but not age, sex, or education, was associated with the inten-
tion to use psychooncological support. However, about 35% of
patients with high distress levels did not intend, whereas 45% of
patients with low distress levels intended or maybe intended to use
support. The general assumption that high distress equates with a
need for support is based on a diagnostic model that recognizes
patients who are at risk for mental disorders.20,35 Predefining a cut‐
off value is a normative standard helpful for screening, but it must
be used carefully, because we screen for normative need but not, per
se, for patients' felt or expressed needs.20Intention predicted uptake behavior, but 7% of patients with no
intention used the service, and 35% of patients with an intention
had not used the service after 4 months. Uptake behavior in ambiva-
lent patients was low (12%). Further studies need to explore the bar-
riers between intention and uptake.18
In the interview, patients with no intention emphasized social sup-
port and well‐being, which supported our quantitative result on low
distress values and aligned with previous research on highly distressed
patients who declined support.10 Patients' negative attitudes about
psychological support and their strong emphasis on self‐determination
and self‐management may indicate a patient concept avoiding help‐
seeking behavior, which is common in mental health‐care settings.10
Similarly, positive attitudinal aspects, knowledge, and coping con-
cepts were important for patients with an intention (yes). Attitudinal
aspects and knowledge are relevant to support‐seeking behav-
ior.24,36,37 Many of these patients had precise ideas of what they
wanted and would get when asking for psychooncological support,
which indicates that mental health literacy, knowledge, and patient
empowerment is an important aspect for service use.8,25
However, attitudes, experiences, or knowledge about support ser-
vices played a negligible role for most ambivalent patients (maybe).
Ambivalent patients stated reasons for and against support: Fears
and uncertainties were described as well as resources and well‐being.
Patients reported a lot of if‐then thinking and seemed to be open to
using the service at a later stage. In our clinical experience, a clear
treatment plan, medical appointments, and a focus on going through
the medical treatment psychologically stabilize patients. Dekker
et al38 argued that an increased distress level might indicate “adaptive
emotional responses, which facilitate coping with cancer” instead of a
maladaptive process. Further studies are needed.
Our study offers a novel, in‐depth qualitative analysis of patients'
supportive care needs, which revealed a threefold intention (yes/
maybe/no) and a divergent pattern of motives for declining
psychooncological support. Intention is relevant here because 67%
of highly distressed patients did not want to make immediate use of
the psychooncology service, but only 35% of these had no intention,
and 32% were ambivalent (maybe).
Our study has several strengths. First, to our knowledge, it is the
first study to monitor uptake behavior of patients after expressing
supportive care needs in a longitudinal study. Second, we qualitatively
analyzed patients' needs, a crucial extension of previous studies. Third,
we assessed a large sample of cancer patients in the early phase of
treatment with equal representation of men and women.5 | STUDY LIMITATIONS
Our limitations are as follows: First, due to the large number of study
participants, we decided against audio records. Instead, we used the
qualitative method of taking notes during the interview and writing
reflective postscripts afterward.29 We countered possible interviewer
bias by relying on a detailed interviewer manual and closely supervis-
ing interviewers. Second, this was a single center study. Our sample
was representative for our clinic and other outpatient oncological set-
tings that use a stepped‐care model and integrate psychooncological
1662 TONDORF ET AL.care (eg, Comprehensive Cancer Centers). Third, oncologists did not
inform 13% of all eligible patients about the study, 28% of eligible
patients did not want more information about the study, and 12%
refused to participate after being informed. We adopted a recruitment
strategy where the consultant oncologist recruited the patients
because it offered several advantages. Oncologists are the first and
closest contact for outpatients, it is a naturalistic setting, and being
invited by a physician to participate in a psychooncological study
might reduce the stigma to accept the invitation. But there is also a
risk of bias if oncologists are more inclined to inform interested,
approachable patients about the study, or to invite patients with spare
time, or who they judged healthy enough to participate.6 | CLINICAL IMPLICATIONS
It is essential to integrate patients' supportive care needs into the clin-
ical distress screening pathway. Patients with an ambivalent intention
to use support might go unrecognized in clinical practice because sup-
portive care needs are usually captured with a dichotomous response
format.13 We propose to assess the supportive care needs of patients
by using a trichotomous response format (yes/maybe/no) at the same
time as assessing psychosocial distress with the DT. The needs of
highly distressed patients who do not intend to use support services
(no) might be better met if approaches to these patients focused on
reducing stigmatization and enhancing self‐determination. In contrast,
it might be better to address the needs of highly distressed, ambiva-
lent patients (maybe) by taking an “if‐then” approach to discussions
about service uptake. Taking the right approach to meet the needs
of each patient group could optimize psychooncological health‐care
delivery. Supportive cancer care should also always include providing
detailed information to all patients about the work psychooncologists
do and the benefits of psychooncological treatments.7 | CONCLUSION
Our study reveals patients' subjective needs linked to psychosocial
distress and uptake of a psychooncology service in cancer outpatients
by using mixed methods. We identified a vulnerable group of ambiva-
lent patients. To optimize distress screening programs, we suggest
that patients' supportive care needs should be addressed and
discussed in routine clinical practice.
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Abstract
Background: Online health interventions are becoming increasingly frequent. However, to prove effective and satisfy the specific needs of cancer 
patients, the standardized steps of development are crucial. This includes structured usability testing to identify potential usability issues in the patient-
specific context early during the development process of a new program.
Methods: Usability of a newly developed online stress management program was prospectively assessed in patients with solid tumors undergoing 
systemic treatment. In an academic computer-lab facility, each patient was asked to fulfill 16 tasks, which covered key components of the program 
including website navigation, login-in to secure area, filling-in forms, accessing audio files, and contacting the trial team. Usability problems during 
these tasks were identified via the think-aloud method and video recording and categorized. General usability was tested with the System Usability 
Scale (SUS). 
Results: A total of 165 tasks from 11 patients were analyzed. Overall usability was high (mean System Usability Scale score 83.6) exceeding the pre-
defined cut-off of 70. Participants solved 97% (160/165) of all tasks, the majority (76%) independently. A total of 122 specific usability problems were 
identified, predominantly concerning website functionality (50.8%) and navigation (29.5%).
Conclusions: Structured usability testing of a novel online intervention in the target population of cancer patients allowed for identification and 
subsequent correction of a significant number of usability problems. This crucial step allowed for a patient-friendly, self-explanatory online program 
with enhanced user-specific functionality, navigation and terminology before embarking on the subsequent randomized trial. 
Keywords: Cancer, internet-based, online, healthcare, usability, technical implications
 
Introduction
The use of internet-based health care interventions is growing 
rapidly enabling certain aspects of mental health care to be delivered 
to the patient without the need for face-to-face interactions. Internet-
based cognitive behavioral therapy for common mental health 
problems such as anxiety disorders and depression can provide effective, 
acceptable and practical health care for those who otherwise might 
remain untreated [1]. Internet interventions can also fill an important 
gap in cancer care. Cancer patients and their caregivers frequently 
use the Internet as a source of information [2, 3] and appropriately 
designed online tools can augment and increase the availability of 
psychosocial care by making participation convenient, confidential 
and less stigmatizing [2, 4]. Nevertheless, problems with high dropout 
rates [5, 6] and low level of engagement have been reported with some 
internet interventions [7]. The usability of an internet intervention is a 
key aspect that determines whether it will be used by the patient or not 
[7]. The few existing guidelines stress the importance of conducting 
formalized usability testing of internet-based health care interventions 
in the target population, hereby assessing whether the end user can 
work with the webpage during specific tasks [2]. Usability is defined 
as ‘‘the extent to which a product can be used by specified users to 
achieve specified goals with effectiveness, efficiency, and satisfaction 
in a specified context of use’ (ISO 9241-11) [8]. In formalized usability 
testing the observed usability problems are grouped to identify flaws 
within the system, ultimately leading to design improvements that 
remove these barriers [9].
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Aim of our study
Usability testing was conducted as part of the development 
process of the web-based stress management program for newly 
diagnosed cancer patients undergoing treatment “STREAM” (STRess 
Aktiv Mindern; Active Stress Reduction). The aim was to improve the 
final website (www.stress-aktiv-mindern.ch) specifically for use by 
cancer patients in a subsequent randomized trial. Here we describe 
the usability testing process, and identify key aspects of online 
intervention tools that are relevant for the development process of 
other online interventions for cancer patients. 
Patients and Methods 
Cancer patients (Table 1) who were undergoing systemic anti-
cancer treatment at the Medical Oncology outpatient department of the 
University Hospital Basel were invited to participate in this study. The 
usability trial was conducted at the computer laboratory of the Center 
of Human-Computer Interaction of the Department of Psychology 
at the University of Basel. The Ethics Committee northwest/central 
Switzerland (EKNZ) approved the study and informed consent was 
obtained from all participant.
Patients first completed a pre-test questionnaire that assessed 
socio-demographic data, medical history, and computer skills. Patients 
then executed 16 tasks (for an overview see Table 2) on the website 
using the ‘think-aloud’ method. This method encourages patients 
to think aloud while solving a problem, thereby giving observers an 
insight into the participant’s cognitive processes. A task designed to 
familiarize patients with the think-aloud method was also included. 
The 16 tasks covered the most important steps within the public area 
of the website (including the website overview, registration, and login 
function) and included a sample module of the secured area of the 
website that covered website navigation, filling-in forms, use of audio 
files, and contacting the trial team. Literature suggests that the majority 
of usability problems and flaws can be identified with as few as eight 
to ten subjects [9]. Overall usability was assessed with the validated 
System Usability Scale (SUS) questionnaire [10]. All usability tasks 
were videotaped and the recordings were used to assess usability. A 
coding manual for the analyses of behavior and performance was 
created by consensual expert judgment and later applied by these 
experts to each participant and task. 
Effectiveness was measured by task success and characterized by 
the degree of help needed (“some help” and “a lot of help”). Problems 
were categorized in terms of terminology, navigation, content, 
functionality, and ‘others’. The severity of each specific usability 
problem was rated by a usability expert based on the impact each 
problem had on the user [9]. Major problems were defined as those 
that had a large impact on the user’s interaction such as creating 
significant delay and frustration or had an impact on a persons’ 
workflow and were experienced by many users. Medium problems 
were those experienced by only a few users that had a large impact 
on the user interaction, or those experienced by many users but 
with a small impact on the user interaction. Efficacy was assessed by 
measuring the time-on-task and the time for navigating to the right 
place for task completion. Self-reported data concerning satisfaction 
with the STREAM tool were collected using a Likert Scale (1–6) and 
after every task. 
Results 
Data from 11 participants (Table 1) who solved 165 tasks (Table 
2) were analyzed. Data analyses according to pre-specified age groups 
(<65/ ≥65 years) did not reveal any significant differences (data not 
shown). 
Overall usability
The mean SUS score was 83.6 indicating that the overall usability 
of the STREAM web-based stress management program clearly 
exceeded the pre-defined cut-off for good overall usability of 70 [11]. 
Effectiveness and efficacy 
Participants solved 97% (160/165) of all tasks (Table 2). Thereof, 
76% (121) tasks were solved independently, 16% (26) with some help, 
and 8% (13) with a lot of help. The mean time spent on tasks was 39 
minutes 47 seconds (SD: 78: 03; range 26: 13–64: 47 minutes). 
Specific usability problems
A total of 122 specific usability problems were identified (Table 
2). These predominantly concerned website functionality (50.8%) and 
navigation (29.5%). 
Satisfaction
Participants indicated they were satisfied with the platform with an 
overall rating of 4.91 (on a scale 1–6). They described the intervention 
as clear, structured, and professional. Moreover, 73% (8/11) of the 
participants indicated that they would continue to use the program 
themselves and all participants stated they would recommend the 
platform to other cancer patient.
Discussion and implications
Our results show that structured usability testing with the target 
population is an important step during the standardized development 
of online health interventions. Our online stress management program 
STREAM is aimed at cancer patients who are undergoing active 
treatment. The overall usability of the STREAM website was rated as 
good and well above the pre-defined cut-off for usability; however, our 
analysis identified 122 specific usability problems. 
A multidisciplinary team consisting of an oncologist, psychologists, 
human-computer interaction researchers, and software engineering 
specialists analyzed and subsequently solved these problems. The 
solutions to these problems were all relatively straightforward. 
Therefore, the crucial step is to first identify the problems, and this is 
greatly facilitated by evaluating the usability of the tool by the target 
patient population. Interestingly, usability in terms of solving tasks 
independently (effectiveness), the time spent on tasks (efficacy), and 
user satisfaction did not differ between young (<65 years) and older 
(≥65 years) patients. The likely explanation for this is that participants 
in both age groups had a similar frequency and duration of Internet 
use (Table 1). The specific usability problems identified in this analysis 
allow some general recommendations: First, it is essential to introduce 
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simple but specific wording and use it consistently throughout the 
program. Second, users should be able to view the entire page without 
using the scroll function. To enable this, text should be concise and 
written in simple to understand language. Third, the intuitive use 
of a webpage is essential and this will solve the majority of minor 
usability problems (Table 2). Finally, a close collaboration with the 
software engineering specialist is extremely important to find good 
and affordable implementation solutions. A limitation of this study is 
that the testing was done in the laboratory and may not reflect the use 
of the program at home. If problems occurred during the use of the 
online program, participants were able to ask for assistance. Second, 
the small sample size may also limit the generalizability of our results. 
However, it is important to note that usability tests are qualitative 
methods that aim to reveal the most important issues that may arise 
during a patient’s interaction with a webpage. 
Table 1. Information on socio-demographics, medical history, internet skills and usage
Demographics Age group <65 years 
(N = 5)
Age group ≥ 65 years 
(N = 6)
Total (N = 11)
Age Mean (SD), range 51 (10.4), 37–63 70.5 (3.4), 68–77 61.64 (12.35), 37–77
Gender Female 2 3 5
Male 3 3 6
Highest educational level Apprenticeship 2 - 2
Business Academy 2 3 5
College - 3 3
University 1 - 1
Medical information 
Cancer type Breast Cancer 2 2 4
Prostate Cancer - 1 1
Lung Cancer - 2 2
Ovarian Cancer - 1 1
Colon Cancer 1 - 1
Glioblastoma 1 - 1
Hodgkin Lymphoma 1 - 1
Current treatmenta Surgery 1 3 4
Radiotherapy - 1 1
Chemotherapy 3 4 7
Hormonal treatment 2 2 4
Other 1 2 3
Ongoing side effects 5 5 10
Internet skills
Internet Usage (Years) Mean (SD), range 15.8 (9.0), 5–35 16.17 (7.37), 8–25 16 (7.71), 5–30
Internet Usage (Frequency)b Mean (SD), range 3 (0), 3–3 2.67 (.52), 2–3 2.82 (.41), 2–3
a) Patients might undergo more than one treatment
b) 0 = several times per month, 1 = once a week, 2 = several times per week, 3 = daily 
In conclusion, our study highlights the importance of conducting 
a professional usability test with the target population during the 
development of an online intervention, as recommended by current 
guidelines [2]. This preparative step allowed for identifying several 
important but easy to resolve usability problems by integrating the 
end user (cancer patients) with the development of the STREAM 
online program. It influenced the development process and enabled 
us to implement a revised version of this tool prior to launching 
the randomized controlled trial (clinicaltrials.gov NCT02289014) 
assessing the efficacy and feasibility [12, 13] of the STREAM tool for 
newly diagnosed cancer patients. 
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Table 2. Overview of usability problems and implications
Overall Usability Problems Number of problems (N = 122) 100%
Category
Terminology (T)
Navigation (N)
Content (C)
Functionality (F)
Other (O)
11
36
5
62
8
9.0
29.5
4.1
50.8
6.6
Problem description Number of 
users affected
Category Severitya Implications
Overall
•	 Required	form	fields	were	not	filled	out 10 /11 F I Mark	mandatory	form	fields	using	color	or	
asterisks 
•	 Unclear error messages 6 / 11 T I Define	terms	clearly	and	use	them	consequently	
•	 Text was not read 3 / 11 C/T II Reduce text to a minimum and use simple-to-
understand language 
•	 Cursor orientation (e.g. participants started typing while mouse 
cursor	was	not	yet	in	a	form	field)
5 / 11 F/ N II Automatically	place	the	cursor	in	the	first	form	
field	
Specific for public area
•	 Substantial information was overlooked 4 / 11 C I Display important information within user’s view, 
without the need to scroll 
•	 Label confusion (e.g. “sign up” versus “register”) 7 / 11 T I Define	terms	clearly	and	use	them	consistently
Specific for private area
•	 Unintentional logouts 6 / 11 F I Prevent unintentional logouts
•	 No feedback was given upon successful saving processes 4 / 11 F I Give feedback to inform the user about the 
system’s current status
•	 System feedback was not noticed 5 / 11 F I Place system feedback within users focus of 
attention
•	 Sequentially navigation within module was not intuitive 11 / 11 N I Use color to differentiate between visited subsites 
and not yet visited subsites 
•	 New interaction possibility (e.g. lightbox) caused disorientation 6 / 11 F II Use known and established interaction patterns
•	 Mapping	between	labels	and	form	field	unclear 6 / 11 N II Place	labels	visually	close	to	the	form	field	
•	 Scale labeling unclear 2 / 11 T II Define	terms	clearly	and	use	them	consistently	
a Classification of problem severity: (I) Major problems that have a large impact on the user’s interaction and are experienced by many users = Immediate changes needed; (II) Medium 
problems experienced by only a few users but with a large impact on the user interaction or experienced by many users but with a small impact on the user interaction = Should be changed 
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A B S T R A C T
Purpose
Being diagnosed with cancer causes major psychological distress; however, a majority of patients
lack psychological support during this critical period. Internet interventions help patients overcome
many barriers to seeking face-to-face support and may thus close this gap. We assessed feasibility
and efficacy of Web-based stress management (STREAM [Stress-Aktiv-Mindern]) for newly di-
agnosed patients with cancer.
Patients and Methods
In a randomized controlled trial, patients with cancer who had started first-line treatment within the
previous 12 weeks were randomly assigned to a therapist-guidedWeb-based intervention or a wait-
list (control), stratified according to distress level ($ 5 v, 5 on scale of 0 to 10). Primary efficacy end
point was quality of life after the intervention (Functional Assessment of Chronic Illness
Therapy–Fatigue). Secondary end points included distress (Distress Thermometer) and anxiety or
depression (Hospital Anxiety and Depression Scale). Treatment effect was assessed with analyses
of covariance, adjusted for baseline distress.
Results
A total of 222 of 229 screened patients applied online for participation. Between September 2014
and November 2016, 129 newly diagnosed patients with cancer, including 92 women treated for
breast cancer, were randomly assigned to the intervention (n = 65) or control (n = 64) group.
Adherence was good, with 80.0% of patients using $ six of eight modules. Psychologists spent
13.3 minutes per week (interquartile range, 9.5-17.9 minutes per week) per patient for online
guidance. After the intervention, quality of life was significantly higher (Functional Assessment of
Chronic Illness Therapy–Fatigue: mean, 8.59 points; 95% CI, 2.45 to 14.73 points; P = .007) and
distress significantly lower (Distress Thermometer: mean,20.85; 95% CI,21.60 to20.10; P = .03)
in the intervention group as compared with the control. Changes in anxiety or depression were not
significant in the intention-to-treat population (Hospital Anxiety and Depression Scale: mean,21.28;
95% CI, 23.02 to 0.45; P = .15). Quality of life increased in the control group with the delayed
intervention.
Conclusion
TheWeb-based stress management program STREAM is feasible and effective in improving quality
of life.
J Clin Oncol 36. © 2018 by American Society of Clinical Oncology. Creative Commons Attribution
Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
INTRODUCTION
Diagnosis of cancer elicits high levels of distress in
a majority of patients,1 which is associated with de-
creased quality of life as well as diminished treatment
tolerance2,3 and potentially worse disease course.4,5
Psychosocial support for patients with cancer is ef-
fective in alleviating distress and improving quality of
life, including fatigue, themost common complaint of
patients with cancer.2,6 However, a majority of newly
diagnosed patients with cancer lack psychosocial
support because of constraints on the part of both
providers and patients.6,7 Use of the Internet, which
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has become an integral part of our lives, has the potential to change this.
At least 70% of patients with cancer use the Internet as a source of
information shortly after diagnosis,8 making it a powerful platform for
reaching these patients. Recent approaches to integrating the Internet
into patient care range frompatient forums to information sites and even
therapeutic games.9,10 Internet programs based on cognitive behavioral
techniques with patient guidance via regular online contact with a health
care professional (ie, therapist-guided programsor guided self-help) have
emerged as particularly effective options. For a range of psychological
disorders, including anxiety disorders and depression in those without
cancer,11,12 therapist-guided online interventions seem similarly effective
as face-to-face interventions.13 The success of Web-based guided self-
help in psychological disorders9,13 coupled with the need to further
improve access to psychosocial support for patients with cancer, espe-
cially outside of inner cities with large cancer centers,6 has boosted
interest in online interventions in oncology. Numerous piloted and
ongoing trials in patients with cancer seek to define suitable indications,
formats, and settings.14 The few larger published randomized controlled
trials15-17 show encouraging results, with improvement in a number of
relevant psychosocial domains, including coping with cancer,15 sexual
functioning,16 and distress17 in breast cancer survivors.
We designed the STREAM (Stress-Aktiv-Mindern) intervention
specifically for the particularly vulnerable period immediately after
first diagnosis of cancer.18 The rationale behind this early intervention
was three-fold. First, distress in patients with cancer peaks shortly after
diagnosis,18 irrespective of cancer type. Second, the time after di-
agnosis is busy with appointments for diagnostics and treatment.
Therefore, the self-management of time and location allowed byWeb-
based interventions9 might be of particular value. Third, successful
early psychosocial interventions have shown potential to affect disease
course beyond psychosocial outcomes.19 We assessed feasibility and
efficacy of our therapist-guided Web-based stress management pro-
gram STREAM for newly diagnosed patients with cancer receiving
first-line treatment.
PATIENTS AND METHODS
Details are provided in the Appendix (online only) and the published
protocol.20 We included adult patients (age $ 18 years) with newly
diagnosed cancer who started first-line treatment (either systemic treat-
ment, including chemotherapy, hormonal treatment, or targeted therapy,
or radiotherapy) no longer than 12 weeks before study registration. Pa-
tients were required to provide written informed consent, read and write in
German, and have Internet access as well as basic computer skills. The
ethics committee approved the study (EKNZ339/13). Patients were
recruited online via the STREAM Web site of STREAM. We randomly
assigned eligible patients at a ratio of one to one using blocked ran-
domization with randomly selected block sizes to an intervention group or
a wait-list control group (Fig 1). Patients were stratified according to
baseline distress using an internationally accepted cutoff of $ 5 points on
the 10-point visual analog scale (VAS) of the Distress Thermometer
(DT).21
Intervention
We developed the Web-based intervention STREAM20 based on
established stress management intervention manuals22 that incorporate
cognitive behavioral– and mindfulness-based stress reduction techniques,
which we adapted to the Web context. STREAM consists of eight modules
(Appendix Table A1, online only), which can be completed in 60 to 90
minutes each. Daily use of downloadable audio files with relaxation and
guided-imagery exercises was encouraged. Participants were asked to
complete one module per week. Our therapists provided weekly written
feedback via integrated secured e-mail.
Patients in the control group underwent their cancer treatment locally
as planned and were recontacted by the study team 8 weeks after random
assignment (T2; Fig 1). After T2 assessments, they received access to the
online program. For patients in both groups, cancer treatment was de-
termined locally, and supportive care according to local standards may also
have included face-to-face psychosocial support and psychotropic drugs.
Assessments
Assessments were conducted electronically directly within the Web-
based program via the open source application LimeSurvey at baseline (T1)
and after the intervention or waiting period (control group), respectively
(T2). In addition, 2-month follow-up (T3) was performed in both groups.
Efficacy End Points
Primary end point was quality of life at T2, assessed using the val-
idated German version of the Functional Assessment of Chronic Illness
Therapy–Fatigue (FACIT-F) questionnaire.23 Minimal clinically mean-
ingful differences are not well defined but have previously been set between
7 and 9 points, both as intraindividual changes and differences in
groups.19,24
T1
Baseline
Patients with
newly diagnosed
cancer undergoing
active treatment
T2
Postintervention
T3
Follow-up
1°end point
FACIT-F
Access to STREAM program
Stratification
high v low distress
(DT ≥ 5 v < 5)
R
8-week online stress
management program
STREAM
Wait-list control
Fig 1. Trial design. DT, Distress Ther-
mometer; FACIT-F, Functional Assessment
of Chronic Illness Therapy–Fatigue; STREAM,
Stress-Aktiv-Mindern.
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Secondary efficacy end points were assessed at the same points in time
and evaluated psychological distress and anxiety or depression using the
validated German versions of the National Comprehensive Cancer Net-
work DT21 and the Hospital Anxiety and Depression Scale (HADS),25
respectively. Effect sizes are expressed as partial eta squared (h2p),
26 with
the following cutoffs to categorize effect sizes into small (0.01), medium
(0.06), and large (0.14), as suggested by Cohen.27
Assessments During Intervention
Usability was evaluated after the first and last module with the System
Usability Scale; scores . 70 represent good usability.28 Therapeutic alliance
between patients and the online therapist was assessed using the Working
Alliance Inventory in its short form (12 items)29 after each module. Total score
ranges from0 to 5, and scores. 3.5 have been rated as goodworking alliances.30
Statistical Analyses and Sample Size Calculation
All analyses were performed in the intention-to-treat (ITT) pop-
ulation defined as all patients who were randomly assigned. The per-
protocol (PP) population included all patients who underwent the pro-
gram in the intended timeframe (ie, the time between random assignment
and T2 assessments did not exceed 16 weeks, which is twice the minimal
duration of the program). To demonstrate a 9-point difference31 in FACIT-F
total score between baseline and T2 (after 8 weeks) in the intervention group
with a statistical power of 0.80 at a significance level of .05 (two sided),
60 participants were needed in each of the two conditions.
Efficacy Analyses
Efficacy outcomes were modeled with analysis of covariance
(ANCOVA), using postscore (T2) as the dependent variable, prescore (T1)
as the covariate, and group allocation (intervention v control) as the
independent variable. ANCOVAs were further adjusted for the stratifi-
cation factor distress (DT $ 5 v , 5). For the follow-up period, score
changes from T2 to T3 were analyzed with paired t tests, separately for each
group (no between-group comparisons). Multiple imputations (n = 99) by
chained equations32 using predictive mean matching33 incorporating all
variables of the linear models underlying ANCOVA were used to impute
missing outcome values.34 To assess the robustness of the results, sensitivity
analyses were conducted for all outcomes in the PP population. In ad-
dition, sensitivity analyses were carried out using other methods for
handling missing data; more specifically, complete-case analyses and last
observation carried forward analyses, as specified in the protocol,20 were
computed for all outcomes in both the ITT and PP populations.
RESULTS
We screened 229 patients, of whom 129 were randomly assigned
between September 11, 2014, and November 24, 2016 (Fig 2). All
patients received first-line cancer treatment, which they started
a median of 17 days (interquartile range [IQR], 6-22 days) and
14 days (IQR, 7-20 days) after signing informed consent in the
intervention and control groups, respectively. Patients were resi-
dents of Switzerland (n = 64), Germany (n = 59), Austria (n = 5),
and the United Kingdom (n = 1). Medical, psychological, and
socioeconomic baseline characteristics are listed in Table 1 and
were balanced between the groups. All 21 patients (control group,
n = 10; intervention group, n = 11) who scored 1 point in the Beck
Depression Inventory suicide item at baseline were immediately
contacted by telephone, but they clearly distanced themselves from
acute suicidal intent.
The intervention was designed to be feasible within 8 weeks.
However, median duration of the online intervention (between
first login to module one and postintervention assessment at T2)
was 11.7 weeks (IQR, 9.1-18.6 weeks). In the intervention group,
52 patients (80.0%) used at least six modules, and 49 (75.4%)
worked with all eight modules. Our psychologists spent a median
time of 165 minutes (IQR, 127-210 minutes) for administering the
online intervention (ie, 13.3 minutes [IQR, 9.5-17.9 minutes] per
patient each week). Usability of the program was rated high, with
a mean System Usability Scale score of 87.5 (IQR, 81.2-95.0) after
module one and of 90.0 (IQR, 82.5-95.0) after module eight. As
a measure of the therapeutic relationship between patient and
online therapist, patients reported a mean score in the Working
Alliance Inventory questionnaire of 3.77 (IQR, 3.38-4.14), similar
to that of previously reported online working alliances.30
Primary and secondary efficacy outcomes are listed in Table 2
and illustrated in Figures 3 and 4. Quality of life (FACIT-F) after
the intervention (T2; the primary end point) was significantly
higher in the intervention group as compared with the control
group (ANCOVA P = .007; Table 2). With a mean increase in total
FACIT-F score of 8.59 (95% CI, 2.45 to 14.73; P = .007) in the ITT
population and of 10.71 (95% CI, 4.49 to 16.94; P = .001) in the PP
population, changes were clinically meaningful.19,24 Effect sizes
were medium27 (h2p = 0.063 and 0.114 in the ITT and PP pop-
ulations, respectively; Table 2). Increased scores within the fatigue
(4.51; 95% CI, 1.81 to 7.22; P = .002), physical well-being (2.01;
95% CI, 0.43 to 3.59; P = .01), and functional well-being subscales
(1.53; 95% CI, 0.11 to 2.95; P = .04) were major contributors to the
increase in total FACIT-F score, whereas social well-being and
emotional well-being scores were not (Table 2.).
Distress on the VAS (scored from 0 to 10) of the National
Comprehensive Cancer Network DTwas significantly lower at T2
in the intervention group as compared with the control (20.85;
95% CI, 21.60 to 20.10; P =.03). As summarized in Table 2,
anxiety and depression (HADS) after the intervention (T2) were
not significantly lower in the intervention as compared with the
control group (P = .15) in the ITT population. However, decrease
in HADS score was statistically significant in the PP population
(22.09; 95% CI, 24.03 to 20.16; P = .03). All results were
confirmed in the prespecified sensitivity analyses (Appendix Table
A2). Figure 4 shows the percentage of patients who reported any
changes in scores between baseline and T2 for all three assessment
tools.
During the 2-month follow-up period of the intervention
group (T2 to T3), quality of life (FACIT-F T2 to T3: mean, 4.69;
95% CI, 20.74 to 10.12; P = .09), distress (DT T2 to T3:
mean,20.29; 95%CI,21.03 to 0.44; P = .4), andmood (HADS T2
to T3: mean, 20.82; 95% CI, 22.28 to 0.65; P = .27) did not
change significantly. In the follow-up phase (ie, after T2), 51
(79.7%) of 64 patients randomly assigned to the control arm opted
to start the STREAM program. For this group of patients, T2
represents the assessments immediately before and T3 the as-
sessments immediately after the online program. In an ITTanalysis
(n = 64), quality of life increased significantly (FACIT-F T2 to T3:
mean, 10.95; 95% CI, 6.18 to 15.71; P , .001) and distress de-
creased significantly (DT T2 to T3: mean, 21.25; 95% CI, 21.95
to 20.55; P = .001) between T2 and T3. Self-reported anxiety and
depression were also lower (HADS T2 to T3: mean, 22.83; 95%
CI,24.29 to21.36; P, .001). Again, results were confirmed in the
prespecified sensitivity analyses (Appendix Table A3, online only).
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Data for individual patients and group means are shown in Ap-
pendix Figure A1 (online only).
DISCUSSION
In this randomized controlled trial, newly diagnosed patients with
cancer reported significantly better quality of life and lower distress
on the DT after participating in the therapist-guided Web-based
stress management program STREAM. Recruitment to the
STREAM study via online channels was successful, and patients in
three countries, corresponding to a geographic area twice as large
as the United Kingdom, were reached. Thus, dissemination of
psychosocial interventions beyond urban centers, where face-to-face
psychosocial interventions are available,35 can be facilitated by
a Web-based approach. The STREAM intervention was feasible in
our population of patients during a period of active treatment of
different types of cancer with good adherence; 80% of patients
worked with at least six of the eight modules.16
Although it is indisputable that quality of life matters, it is also
inherently difficult tomeasure.36 To ensure robust and clinically relevant
data, we rely on well-validated and standardized questionnaires.1,23,25
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Fig 2. Patient flow (CONSORT diagram). ITT, intention to treat; RCT, randomized controlled trial.
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There is no clear cutoff for clinically meaningful increases in overall
quality of life in the FACIT-F score. However, on the basis of previous
studies, changes reported in the postintervention scores of this trial were
in a range that is considered highly noticeable to patients.19,24 Quality-
of-life analyses are often complicated by a large number ofmissing data.
In our study, the low number of missing data (90.7% of all randomly
assigned patients completed the primary assessment at T2) and ro-
bustness of the sensitivity analyses (Appendix Tables A2 and A3), in-
crease reliability of patient-reported outcomes.
Although the primary efficacy end point of better quality of
life after the STREAM interventionwas clearly met, the effect of the
intervention on distress is less clear cut. The DT is an assessment
tool that allows patients to summarize all subjective aspects of
distress in a single number (VAS, 0 to 10). In its simplicity, the DT
therefore has the advantage of covering various dimensions of
distress, including physical, functional, social, socioeconomic,
spiritual, and emotional distress.21 However, the weight that pa-
tients assign, whether consciously or not, to each dimension is not
discernible from the DTscore. In contrast, the HADS questionnaire
covers exclusively the emotional dimension of distress, but it does
so in greater depth.25 Whereas self-reported distress on the DT
was lower after STREAM, with a small to medium effect size27
(h2p = 0.043 and 0.069 in the ITTand PP populations, respectively),
emotional distress as assessed by HADS did not change. This leads
to the hypothesis that STREAM primarily affects dimensions of
distress other than anxiety or depression. Of note, in our pop-
ulation, HADS scores at baseline were rather low (mean, 12; IQR,
7-17), whereas baseline DTscores were high (mean, 6; IQR, 5-8). It
is therefore conceivable that a potential impact of STREAM on the
emotional dimension of distress (anxiety and depression) cannot
be assessed conclusively in our population. A study tailored spe-
cifically toward patients with high baseline levels of anxiety or
depression would be more appropriate to answer this specific
question.
Although STREAM was designed for and open to all newly
diagnosed patients with cancer, women with breast cancer un-
dergoing curative treatment represented the vast majority of the
study population. This leaves uncertainty regarding generalizability
Table 1. Baseline Demographic and Clinical Characteristics
Characteristic
No. (%)
All Patients
(N = 129)
Control
Group
(n = 64)
Intervention
Group
(n = 65)
Age, years
Median 52 53 51
IQR 46-58 46-58 46-57
Sex
Female 109 (84.5) 56 (87.5) 53 (81.5)
Male 20 (15.5) 8 (12.5) 12 (18.5)
Tumor origin
Breast 92 (71.3) 47 (73.4) 45 (69.2)
Gynecologic tract 7 (5.4) 5 (7.8) 2 (3.1)
Lung 5 (3.9) 3 (4.7) 2 (3.1)
CNS/head and neck 4 (3.1) 1 (1.6) 3 (4.6)
Lymphoma 11 (8.5) 4 (6.2) 7 (10.8)
Skin/soft tissue 1 (0.8) 1 (1.6) 0 (0.0)
GI tract 7 (5.4) 2 (3.1) 5 (7.7)
Urogenital tract 2 (2.0) 1 (1.6) 1 (1.5)
Disease stage
Localized 111 (86.0) 55 (85.9) 56 (86.2)
Metastatic 18 (14.0) 9 (14.1) 9 (13.8)
Treatment
Radiotherapy 16 (12.4) 8 (12.5) 8 (12.3)
Chemotherapy 75 (58.1) 40 (62.5) 35 (53.8)
Hormonal therapy 32 (24.8) 14 (21.9) 18 (27.7)
Radiochemotherapy 4 (3.1) 1 (1.6) 3 (4.6)
Other 2 (1.6) 1 (1.6) 1 (1.5)
Treatment goal
Curative 117 (90.7) 58 (90.6) 59 (90.8)
Palliative 12 (9.3) 6 (9.4) 6 (9.2)
Marital status
Married 81 (62.8) 39 (60.9) 42 (64.4)
Married, separated 2 (1.6) 1 (1.6) 1 (1.5)
Single 26 (20.2) 12 (18.8) 14 (21.5)
Divorced 16 (12.4) 9 (14.1) 7 (10.8)
Widowed 4 (3.1) 3 (4.7) 1 (1.5)
Highest education
Compulsory school 2 (1.6) 1 (1.6) 1 (1.5)
Apprenticeship 32 (24.8) 16 (25.0) 16 (24.6)
College 44 (34.1) 19 (29.7) 25 (38.5)
University 48 (37.2) 25 (39.1) 23 (35.4)
Other 3 (2.3) 3 (4.7) 0 (0.0)
Monthly household income,
V (n = 107)
, 1,200 2 (1.9) 0 (0.0) 2 (3.8)
1,200-2,500 7 (6.5) 6 (11.1) 1 (1.9)
2,500-4,900 35 (32.7) 18 (33.3) 17 (32.1)
4,900-8,100 36 (33.6) 18 (33.3) 18 (34.0)
8,100-12,200 19 (17.8) 9 (16.7) 10 (18.9)
. 12,200 8 (7.5) 3 (5.6) 5 (9.4)
Using complementary
medicine
(n = 116)
Yes 31 (26.7) 17 (30.4) 14 (23.3)
No 51 (44.0) 23 (41.1) 28 (46.7)
I don’t know 34 (29.3) 16 (28.6) 18 (30.0)
Currently seeing a therapist
Yes 45 (34.9) 27 (42.2) 18 (27.7)
No 84 (65.1) 37 (57.8) 47 (72.3)
Currently using psychotropic
drugs
Yes 17 (13.2) 11 (17.2) 6 (9.2)
No 111 (86.0) 53 (82.8) 58 (89.2)
I don’t know 1 (0.8) 0 (0) 1 (1.5)
(continued in next column)
Table 1. Baseline Demographic and Clinical Characteristics (continued)
Characteristic
No. (%)
All Patients
(N = 129)
Control
Group
(n = 64)
Intervention
Group
(n = 65)
Baseline FACIT-F score
Median 106.0 108.3 101.0
IQR 84.2-123.0 87.8-124.0 81.0-120.0
Baseline distress (DT)
Low 30 (23.3) 14 (21.9) 16 (24.6)
High (score $ 5) 99 (76.7) 50 (78.1) 49 (75.4)
Baseline HADS score
Median 12 12 13
IQR 7-17 7-16 7-18
NOTE. No significant differences (P , .05) between groups were identified for
any category (as determined by Wilcoxon or Kruskal-Wallis test or Pearson
x2 test).
Abbreviations: DT, Distress Thermometer; FACIT-F, Functional Assessment of
Chronic Illness Therapy–Fatigue; HADS, Hospital Anxiety and Depression Scale;
IQR, interquartile range.
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of the results, particularly toward men and toward the palliative
setting. Women with breast cancer are known to have the largest
social media network in the cancer community, which likely
allowed for effective online recruitment. The presence of other
cancer groups in the Internet community is only emerging, with
platforms such as that created by the Movember Foundation for
men with cancer.37 Such platforms may allow for integrating more
men into future studies. If targeted specifically, men with prostate
cancer also seem to be reachable via the Internet, as shown by an
Australian self-help online program, which integrated a patient
forum called My Road Ahead.38
At baseline, before random assignment, more patients in the
control group reported face-to-face psychological support and use
of psychotropic drugs than in the intervention group, although
the number was not statistically significant. Data on the amount
of time spent face to face with local psychologists during the course
of the trial were not collected; hence, potential bias cannot be
quantified. In contrast, attention bias toward the intervention
group, possibly introduced by the time our STREAM psychologists
spent online with the patients, may have affected outcome in-
versely. Because we opted for a care-as-usual (ie, wait-list) rather
than active control, this will need to be differentiated in future
studies.
Await-list controlled design is generally accepted to control
for the effect of time on the outcome of interest. However, the
duration of the wait and consequently the timing of assessments
(T2) for the control group are prospectively defined and rigid,
whereas the timing of assessments (T2) in the interventions
group is dependent on the duration of the intervention and
therefore more variable. Hence, time sensitivity is only partially
accounted for. This is also true for our study, where median time
between T1 and T2 was 9.4 weeks (IQR, 8.6-12.1 weeks) for the
intervention group but was shorter in the control group
(median, 8.7 weeks; IQR, 8.3-9.3 weeks). Dynamic wait-list
controlled designs have been proposed to minimize this po-
tential bias.39
Another shortcoming of our trial is that we only show
a benefit in distress and quality of life for patients early after
Table 2. Efficacy Outcomes
Measure
ITT Population
(n = 129)
PP Population*
(n = 95)
D Means† (95% CI) P ES (h2p)‡ D Means† (95% CI) P ES (h
2
p)‡
Quality of life including fatigue (FACIT-F; 40 items; score, 0-160) 8.59§ (2.45 to 14.73) .007 0.063 10.71 (4.49 to 16.94) .001 0.114
Physical well-being (seven items; score, 0-28) 2.01 (0.43 to 3.59) .01 2.64 (1.02 to 4.25) .002
Social well-being (seven items; score, 0-28) 0.44 (20.95 to 1.82) .53 0.41 (21.13 to 1.96) .60
Emotional well-being (six items; score, 0-24) 0.24 (20.77 to 1.25) .64 0.68 (20.38 to 1.75) .21
Functional well-being (seven items; score, 0-28) 1.53 (0.11 to 2.95) .04 1.65 (0.04 to 3.26) .05
Fatigue score (13 items; score, 0-52) 4.52 (1.81 to 7.22) .002 5.26 (2.37 to 8.16) .001
DT (score, 0-10) 20.85 (21.60 to 20.10) .03 0.043 21.11 (21.95 to 20.26) .01 0.069
HADS (14 items; score, 0-42) 21.28 (23.02 to 0.45) .15 0.019 22.10 (24.03 to 20.16) .03 0.049
NOTE. Results of analysis of covariance for postintervention scores (T2), with baseline scores (T1) as covariates, adjusted for baseline distress (stratification factor).
Abbreviations: DT, Distress Thermometer; ES, effect size; FACIT-F, Functional Assessment of Chronic Illness Therapy–Fatigue; HADS, Hospital Anxiety and Depression
Scale; ITT, intention to treat; PP, per protocol.
*PP population was defined as all patients for whom time between random assignment and T2 assessments did not exceed 16 weeks.
†Treatment effects estimated by analysis of covariance are reported as difference (D) in scores of group means for intervention v control group.
‡ESs are expressed as partial eta squared, with the cutoffs small (0.01), medium (0.06), and large (0.14). Multiple imputations were used to handlemissing data. Results
did not change significantly with other methods for handling of missing data (complete-case (CC) analysis or last observation carried forward (LOCF) analysis; Appendix
Table A2, online only).
§Primary end point of the trial.
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diagnosis, with a limited follow-up. It is conceivable, however, that
such an early intervention19 may be of particular importance to
prevent chronification of distress.40 Whether lower distress and
increased quality of life after STREAM translate into better
treatment tolerance and favorable disease course warrants addi-
tional studies.
The unique and common feature of study participants in this
trial was a recent diagnosis of cancer. In contrast, the few reported
randomized controlled trials on online support for patients with
cancer have mainly focused on cancer survivors (ie, interventions
later in the disease trajectory). In a randomized, wait-list con-
trolled trial, breast cancer survivors (on average, 3 years after
initial diagnosis) who participated in an online program in a similar
therapist-guided format as presented here reported significantly
improved sexual functioning (the primary end point of the trial) as
compared with the wait-list control group.16 Breast cancer survivors
were also the target population in the randomized trial for the Coping
With Cancer Workbook.15 Women who participated in this Web-
based self-help program reported better self-efficacy in coping with
cancer. Overall quality of life was not reported. The BREATH (Breast
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Cancer eHealth) intervention,17 a Web-based intervention based on
cognitive behavioral techniques but without therapist guidance, led to
reduced distress in breast cancer survivors; however, it was not
sustained during the 10-month follow-up.
In conclusion, with digital natives approaching an age that
places them at risk for developing age-associated diseases, in-
cluding cancer, use of the Internet in the health care setting will
likely further increase. In this randomized trial, we found that
a Web-based, guided self-help intervention resulted in a clinically
meaningful improvement in quality of life. Our results indicate that
Web-based, guided self-help has potential to efficiently support
newly diagnosed patients with cancer.
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Appendix
Patients and Methods
Patient Eligibility Criteria and Recruitment
Rationale and design of this randomized trial have been published.20 We included adult patients (age $ 18 years) with newly
diagnosed cancer who started first-line treatment (either systemic treatment, including chemotherapy, hormonal treatment, or
targeted therapy, or radiotherapy) no longer than 12 weeks before study registration. Patients were required to provide written
informed consent, read and write in German, have Internet access, and have basic computer skills. To obtain informed consent,
a therapist provided detailed information about the study via telephone and went point by point through the informed consent
form. The informed consent form was then sent to the patient, who, if in agreement, sent the signed paper form back via post mail.
The Ethics Committee of Northwestern and Central Switzerland approved the study (EKNZ 339/13). The trial is registered at
ClinicalTrials.gov (ClinicalTrials.gov identifier: NCT02289014).
For safety reasons, patients were assessed at baseline for suicidal tendency by the suicide item of the Beck Depression Inventory
(Green KL, et al: J Clin Psychiatry 76:1683-1686, 2015). Our online program was not designed to support suicidal patients in acute
crises; therefore, patients with a score higher than 1 were contacted by telephone and referred to immediate local support.
Information on medical history was obtained from the patients during baseline assessments and confirmed by their treating
physicians, who we contacted by e-mail or telephone.
Patient Recruitment
Patients were recruited via the public Web site of STREAM (Stress-Aktiv-Mindern). To foster recruitment, we linked and
distributed information about the trial via the following channels: links from health-related Web sites, such as cancer leagues,
cancer hospitals, and patient advocate Web sites to the public Web site of STREAM; distribution of flyers in hospitals and during
cancer conferences; communication to medical lay press; and paid advertisement via Google and Facebook.
Study Design
We randomly assigned eligible patients at a ratio of one to one using blocked randomization with randomly selected block sizes
to an intervention group or a wait-list control group (Fig 1). Patients were stratified according to baseline distress, using an
internationally accepted cutoff of $ 5 points on the 10-point visual analog scale of the Distress Thermometer.21
Intervention
We developed the Web-based intervention STREAM20 based on established stress management intervention manuals22 that
incorporate cognitive behavioral– and mindfulness-based stress reduction techniques, which we adapted to the Web context.
STREAM aims at improving intra- and interpersonal coping strategies, thereby reducing perceived stress, anxiety, and fatigue as
well as enhancing quality of life. STREAM consists of eight modules (Appendix Table A1), which can be completed in 60 to 90
minutes each. Each module starts with a short mindfulness breathing exercise followed by text-based psychoeducation, reflection
on current individual emotional status, and acquisition of coping strategies including several exercises and worksheets. Daily use of
downloadable audio files with relaxation and guided-imagery exercises was encouraged. Participants were asked to complete one
module per week. Access to the next module was provided after the weekly online feedback of a therapist. Patients who had to
interrupt the program for medical or personal reasons were regularly contacted and offered continuation. The total duration of the
program was not limited. Therapists monitored participants’ progress in the program and contacted the participants via an
integrated and secured e-mail system to provide feedback and structure. Patients could use the integrated e-mail system to contact
their therapist whenever they felt the need to and were informed that the therapist would answer within 3 working days. Whenever
patients did not log in to the program for 7 days, therapists sent an e-mail reminder.
Therapists were four female psychologists with Master’s degrees in clinical psychology and clinical experience in psycho-
oncology. Three of them were in postgraduate psychotherapy training programs, and one was a licensed psychotherapist (C.U.).
This core team was supported by seven psychologists with Bachelor’s degrees in psychology, who worked under supervision of the
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licensed psychotherapist. All therapists were trained by the psychological study team leaders (A.G., C.U.) in applying the STREAM
program and met for weekly discussions, with input by a medical oncologist (V.H.), to align procedures and strategies. For data
protection, the program is password protected and secured by Secure Socket Layer encryption.
Control
Patients in the control group underwent their cancer treatment locally as planned and were recontacted by the study team
8 weeks after random assignment (T2; Fig 1). After T2 assessments, they received access to the online program. For patients in both
groups, cancer treatment was determined locally, and supportive care, according to local standards, may also have included face-to-
face psychosocial support and psychotropic drugs.
Assessments
Assessments were conducted electronically directly within theWeb-based program via the open source application LimeSurvey
at baseline (T1) and after the intervention or waiting period (control group), respectively (T2). In addition, 2-month follow-up
(T3) was performed in both groups. Feasibility was assessed at two different levels: feasibility of online recruitment and feasibility
for patients to participate in the STREAM program while undergoing first-line treatment. According to the study protocol,
feasibility of online recruitment was confirmed when 120 patients (ie, the number needed to assess the primary efficacy outcome)
were recruited within a 2-year period; feasibility of participation during treatment was prespecified as a descriptive end
point—more specifically, the percentage of completers’ in the intention-to-treat (ITT) population, where completers’ were defined
as patients who worked with at least six of eight modules.
Efficacy End Points
Primary end point was quality of life at T2, assessed in the validated German version of the Functional Assessment of Chronic
Illness Therapy–Fatigue (FACIT-F) questionnaire.23 The first 27 items are common to all Functional Assessment of Cancer Therapy
(FACT) questionnaires and cover different domains of quality of life, specifically physical well-being (seven items), social well-being
(seven items), emotional well-being (six items), and functional well-being (seven items). The last 13 items focus on various aspects
of fatigue, a key aspect of quality of life in patients with cancer, particularly during active treatment.6 FACIT-F total score ranges
from 0 to 160. Higher scores represent better quality of life. Minimal clinically meaningful differences are not well defined but have
previously been set between 7 and 9 points, both as intraindividual changes and differences in groups.19,24 For our sample size
calculation, we relied on the more stringent definition of 9 points. We chose FACIT-F, rather than the distress thermometer (DT), as
primary outcome because overall well-being, reflected by the multidimensional FACIT-F questionnaire, seems clinically more
important than changes in a single domain.23 Also, FACIT-F is better validated as outcome measure than DT, which often serves as
screening tool.21
Secondary efficacy end points were assessed at the same points in time and evaluated psychological distress and anxiety and
depression using the validated German versions of the National Comprehensive Cancer Network DT21 and the Hospital Anxiety
and Depression Scale (HADS),25 respectively. Effect sizes are expressed as partial eta squared (h2p),
26 with the following cutoffs to
categorize effect sizes into small (0.01), medium (0.06), and large (0.14), as suggested by Cohen.27 Subgroup analyses are highly
explorative and, therefore, not part of this report.
Assessments During the Intervention
Usability was evaluated after the first and last module with the System Usability Scale (SUS), where scores. 70 represent good
usability.28 Therapeutic alliance between patients and online therapist was assessed using the Working Alliance Inventory (WAI) in
its short form (12 items),29 adapted with 2 additional items specific to the online context after each module. Total score ranges from
0 to 5, and scores . 3.5 have been rated as good working alliances.30
Statistical Analyses and Sample Size Calculation
R version 3.4.0 software (R Foundation for Statistical Computing, Vienna, Austria) was used for all analyses. All analyses were
performed in the ITT population defined as all patients who were randomly assigned. The per-protocol (PP) population included
all patients who completed the program in the intended timeframe (ie, the time between random assignment and T2 assessments
did not exceed 16 weeks, which is twice the minimal duration of the program).
To demonstrate a 9-point difference31 in FACIT-F total score between baseline and T2 (after 8 weeks) in the intervention group
with a statistical power of 0.80 at a significance level of .05 (two sided), 60 participants were needed in each of the two conditions.
We assumed normally distributed data in both groups with a standard deviation of6 18 (Pandey M, et al: World J Surg Oncol 3:63,
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2005). Data preparation of all continuous dependent variables included tests for normality, homogeneity of variances, and ex-
amination of outliers.
Efficacy Analyses
Efficacy outcomes (primary end point of FACIT-F; secondary end points of DT and HADS) were modeled with analysis of
covariance (ANCOVA), using the postscore (T2) as dependent variable, the prescore (T1) as covariate, and group allocation
(intervention v control) as independent variable. ANCOVAs were further adjusted for the stratification factor distress (DT$ 5 v, 5).
Multiple imputations (n = 99) by chained equations32 using predictive mean matching33 incorporating all variables of the linear
models underlying ANCOVA were used to impute missing outcome values.34 To assess the robustness of the results, sensitivity
analyses were conducted for all outcomes in the perprotocol population. In addition, sensitivity analyses were carried out using
other methods for handling missing data; more specifically, CC analyses and LOCF analyses, as specified in the protocol,20 were
computed for all outcomes on both the ITT and PP populations.
2-Month Follow-Up Analyses
For the follow-up period, score changes from T2 to T3 were analyzed with paired t tests separately for each group (no between-
group comparisons). Again, multiple imputations were used for missing data. Sensitivity analyses were conducted using CC and
LOCF analyses in the ITT and PP populations.
Role of Funding Bodies
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for
publication.
Table A1. Content of Web-Based Stress Management Program STREAM
Module Psychoeducation Reflection on Status Strategies and Exercises
Introduction: What is stress? Nature of stress in general and specifically
in relation to cancer
My individual stressors Diary,* body scan†
Bodily stress reduction Bodily sensations during stress and
adverse effects of anticancer treatment,
focus on fatigue
My individual bodily stress
reactions
Stress protocol*
Cognitive stress reduction Thoughts and their interaction with
emotions and bodily sensations
My negative thought patterns Progressive muscle relaxation†
Emotional stress reduction Feelings and cancer-related emotions
such as anxiety and worries
My feelings and worries Walk on the beach,† relaxation protocol,*
negative thought cycle,† relationship of
body position and thoughts,* thinking
styles and reflection*
Mindfulness and acceptance of thoughts
and emotions
Meaning and implementation of
mindfulness and acceptance in daily life
(as opposed to active strategies learned
in modules one to four)
My definition and experiences
with acceptance
Thoughts on clouds,† mountain
meditation,† emotional emergency kit†
Activation of resources: quality of life and
pleasure
Introduction of models for balance
between burden and resources
My individual resources Acceptance story*†
Activation of resources: social network
and communication skills
Social network and the role of a supportive
environment
My individual social network and
current needs
Body scan*†
Summary Overview and documentation of the last
7 weeks
My experiences with the
program
Integration of mindfulness,* winter walk,†
spring awakening,† health cycle,*
planning activities,* week planner,*
friendly feelings toward our own body,†
enjoyment training,* communication
skills,* walk on the beach,† winter
walk,† spring awakening,† four
seasons†
Abbreviation: STREAM, Stress-Aktiv-Mindern.
*Instructions and worksheets.
†Audio file: story, relaxation, or guided imaginary exercise.
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Scores for individual patients Group means
Mean (IQR)
FACIT-F 
Control 
Intervention 
DT 
Control 
Intervention 
HADS 
Control 
Intervention 
40
80
120
160
Control group
Low baseline distress
Control group
High baseline distress
Intervention group
Low baseline distress
Intervention group
High baseline distress
40
80
120
160
0.0
2.5
5.0
7.5
10.0
0.0
2.5
5.0
7.5
10.0
0
10
20
30
40
0
10
20
30
40
T1 T2 T3 T1 T2 T3 T3 T2 T1 
108.3
(87.8-124.0)
110.0
(98.0-121.0)
125.0
(110.0-136.0)
101
(81.0-120.0)
120
(101.0-132.0)
120.0
(107.0-138.0)
6
(5-8)
6
(4-7)
4
(3-6)
6
(5-8)
5
(3-6)
4
(3-6)
12
(7-16)
11
(7-14)
8
(5-11)
13
(7-18)
9
(6-13)
8
(6-12)
Control group
Low baseline distress
Control group
High baseline distress
Intervention group
Low baseline distress
Intervention group
High baseline distress
Control group
Low baseline distress
Control group
High baseline distress
Intervention group
Low baseline distress
Intervention group
High baseline distress
Fig A1. Individual patients’ scores and group means for all time points. DT, Distress Thermometer; HADS, Hospital Anxiety and Depression Scale; IQR, interquartile
range; FACIT-F, Functional Assessment of Chronic Illness Therapy–Fatigue.
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5. Discussion 
The studies presented in this thesis succeeded to identify patients with a need for 
support. We first identified a vulnerable group of ambivalent patients with high distress 
levels and ‘low uptake behavior’, i.e. those patients who had refrained from psycho-
oncological support. Secondly, we successfully developed the tailor-made online 
intervention tool STREAM for newly diagnosed cancer patients. Usability of STREAM 
was tested, and the results were taken into account for the finalization of the STREAM 
program. Third and most importantly, we demonstrated the feasibility and efficacy of 
STREAM in a randomized, controlled clinical trial in the target population during active 
treatment of various types of cancer. Newly diagnosed cancer patients reported 
significantly better QoL and less distress after participating in STREAM. Detailed 
discussion of the individual studies is provided in the publications attached (section 4). 
Below, some findings that should be integrated into routine clinical practice are briefly 
summarized.  
5.1 Identifying patients with a need for support  
Focusing on the patients’ intention to seek support and their actual use of psycho-
oncological assistance, we identified a vulnerable group of ambivalent patients with high 
distress levels and low uptake behavior. The distress indicator DT was used with a 
dichotomous answering option (yes/no). By means of qualitative content analyses, we 
detected the “maybe” group which was lost when using the dichotomous approach. 
Ambivalent patients stated reasons for and against support. Therefore, patients with an 
ambivalent intention to accept support might stay unrecognized in clinical practice when 
using the dichotomous answering option as their answer to this question is usually “no”. 
It is difficult to systematically capture emotional turmoil due to the highly variable 
conditions of cancer patients. Type of disease and treatment as well as survival 
perspectives are highly heterogeneous in this patient population. Thus, the clinical 
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implication of our results is that the need of supportive care in these patients should be 
assessed by using a trichotomous response format with the answer possibilities “yes”, 
“maybe”, and “no” within the DT assessment. In response to our research results, we 
are currently testing this approach at the University Hospital Basel. Moreover, we 
suggest to routinely re-evaluate the distress levels of patients to more fully understand 
the changes in the patients’ willingness to accept mental support. Assessment of the 
needs of psycho-oncological patients is hampered by the "emotional rollercoaster rides" 
experienced by many patients. Moreover, cancer patients with untreated psychosocial 
distress are at risk of non-adherence to cancer treatment [DiMatteo et al., 2000; 
Kennard et al., 2004; Markovitz et al., 2017], poorer QoL [Stark et al., 2002], and 
psychiatric comorbidities [Kissane, 2014; Mitchell et al., 2011; Zabora et al., 2001]. In 
addition, clinical embedding of the mental health aspect of physically ill patients might 
be helpful to overcome stigmatization of psychological face-to-face care in routine 
practice [Tondorf et al., 2018]. If the resistance to face-to-face support is pronounced, 
a low-threshold option, such as the STREAM program, would be of particular merit. 
5.2 Tailored online intervention - the impact of usability testing  
To detect even small flaws of an online intervention program, structured usability 
testing in the target population is of critical importance. As pointed out in the literature 
[Leykin et al., 2012], the usefulness and effectiveness of online tools hinges on the easy 
and reliable handling of the underlying technology. 
The aim of this study was to adjust the final website to the specific use by our 
target population. In this preparative step, we detected as many as 122 specific usability 
problems [Grossert et al., 2019]. These predominantly concerned website relevant 
topics of functionality (50.8%) and navigation (29.5%).  
A multidisciplinary team consisting of an oncologist, psychologists, human-
computer interaction researchers, and software engineering specialists analyzed the 
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problems and subsequently solved them. The specific usability problems identified in 
this analysis allow some general recommendations. First, it is essential to use simple 
but specific wording and to use it consistently throughout the program. Second, users 
should be able to view the entire page without having to use the scroll function. Thus, 
the text should be concise and written in a language that is readily understood. Third, 
the intuitive use of a webpage is essential, and this will solve the majority of minor 
usability problems. Finally, close collaboration with the software engineering specialist 
is indispensable to find effective and affordable solutions.  
By removing the sources of these errors, we were able to implement a revised 
version of the STREAM tool prior to launching the randomized, controlled trial assessing 
the efficacy and feasibility of the program. Reliable technical use provided the 
foundation for the modest dropout rate (i.e. less than 10%) and highly satisfactory 
outcome of the trial [Grossert et al., 2018].  
5.3 Feasibility and efficacy of STREAM  
5.3.1 Feasibility  
Feasibility of the STREAM program was assessed on the basis of successful 
recruitment, high completion rate with a low dropout rate, as well as the established 
therapeutic alliance. Recruitment to the STREAM study was successful, and we 
reached patients in the German-speaking countries Switzerland, Germany, and Austria. 
For detailed patient characteristics please see Table 1 of the publication [Grossert et 
al., 2018] in section 4.  
Recruitment was successful with 129 included patients. Although recruitment of a 
sufficiently high number of patients was a crucial step. Our recruitment strategy included 
online advertising (e.g. Google AdWords) since we were aware that one of the most 
frequent reasons for trial discontinuation is poor recruitment. Clearly, premature trial 
discontinuation is accompanied by a waste of administrative and financial resources as 
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well as distorted perception of a specific research field because of unpublished results 
[Kasenda et al., 2014]. As a subproject, we contrasted inclusion rate and costs of two 
online advertising channels (Google AdWords [GAW] and Facebook advertisement 
[FA]) over a period of 2 months with those associated with traditional recruitment 
strategies (e.g. flyers, posters, advertisement in magazines, and word-of-mouth). 
Overall, GAW performed better than FA and resulted in significantly higher registration 
rates (nGAW 32 vs. nFA=19) and inclusion rates (nGAW=14 vs. nFA=8). During the 2-month 
control period before implementation of any active online advertisement, the recruitment 
rate was markedly lower (registration ncontrol=9; inclusions ncontrol=4). The cost per 
included patient was CHF 265.17 for GAW and CHF 459.86 for FA. Our results are in 
line with those of a review [Lane et al., 2015] identifying Google to be the more effective 
platform for the recruiting of trial subjects, whereas Facebook performed better when 
recruiting younger participants (age <25 years). These evaluations provided insight into 
the reachability of cancer patients via online advertisement (publication in preparation). 
The STREAM program was completed by 80% (n=52) of participants. Completion 
was defined by finalizing three-quarters of the program consisting of 8 modules. 
Remarkably, 75% (n=49) of patients in the intervention group completed all 8 modules. 
Moreover, time to completion of the STREAM program (i.e. the time between the start 
of module 1 and post-intervention assessment) was approx. 12 weeks (mean 
11.7 weeks; IQR 9.1 to 18.6). The program was intended to be completed within 
8 weeks, but it turned out that due to the burden caused by the therapies and side 
effects, a somewhat longer period was required to complete the modules. However, the 
dropout rate was low (n=11; 8.5%). Thus, we achieved a high completer rate and low 
dropout rate, which is impressive when the context of the disease and demands on the 
patients are considered. In the literature, high dropout rates are documented in this 
patient population [Melville et al., 2010; Wootten et al., 2014a]. While female gender, 
sufficient time, and personalized intervention are predictors for higher compliance with 
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the online intervention [Beatty & Binnion, 2016], illness factors (specifically side effects 
of cancer treatment), distress, and technical barriers appear to be the main reasons for 
poor compliance [Beatty et al., 2017; Brebach et al., 2016; Christensen et al., 2009]. 
Moreover a good adherence and therefore low dropout rate has an important clinical 
implication – poor adherence limits exposure to the full STREAM program, thus 
diminishing their psycho-oncological support [Eysenbach, 2005]. In turn, this may 
impact on psychological health outcomes [Donkin et al., 2011]. In addition, patients may 
be at risk of entering a vicious circle; higher distress leads to lower compliance, and this 
may result in more side effects and even shorter overall survival.  
A possible reason for the high completion rate is the successful development of a 
therapeutic working alliance. STREAM has been designed as a minimal-contact 
program; this includes a weekly written contact with a psychologist. The overall 
therapeutic working alliance between patient and therapist was good (WAI mean 3.77 
[IQR 3.38 to 4.14], [Berger, 2016]). As stipulated in the literature [Rehse & Pukrop, 
2003], a psychosocial intervention should be planned for at least 12 weeks, which is 
approximately the duration required for a stable relationship.  
Besides the good and stable working alliance, we observed an improvement of 
the working alliance during the program between the modules, with the highest rate 
achieved in the final module. In-depth analysis of the dynamics of the working alliance 
has not yet been conducted. From the patient’s perspective, criteria of a good working 
alliance are trust, empathy, sympathy, sufficient time, a solution-oriented approach, and 
a respectful interaction [Hermer & Röhrle, 2008]. We took these criteria into account 
when developing the STREAM program, based on the notion that a good therapeutic 
relationship is a key predictor of successful psychological treatment in general [Grawe 
et al., 1994]. The presence of a therapeutic relationship between the patient and 
healthcare professional in online interventions is well established [Anderson et al., 2012; 
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Bisseling et al., 2019; Klasen et al., 2013; Knaevelsrud & Maercker, 2007; Preschl et 
al., 2011]. 
Interestingly, the time per patient spent by psychologists in the STREAM program 
was low. The psychologists spent a median time of 165 (IQR 127 - 210) min for 
administering (e.g. time for administration, reading the module progress and formulating 
written answers) the online intervention with an average of 13.3 (IQR 9.5 to 17.9) min 
per patient each week. Our findings support the suggestion that the length of time 
devoted to patients during online interventions can be considerably reduced, and that 
the extent of support (e.g. number of messages) does not affect the working alliance 
[Andersson et al., 2008; Klein et al., 2009]. The provision of support and feedback when 
requested seems to be satisfactory [Andersson, 2016]. These aspects were of critical 
importance to us during the conduct of the clinical trial and support of the participants. 
5.3.2 Efficacy: QoL and distress improvement  
In our randomized, controlled trial, newly diagnosed patients with cancer reported 
significantly better QoL and lower distress after participating in the therapist-guided 
online stress-management intervention. We discussed our finding in detail in the 
publication [Grossert et al., 2018]. Below, some aspects relevant to the existential 
dimension of a cancer diagnosis are summarized.  
We showed that QoL measured with the FACIT-F at the post-intervention time 
point was significantly higher in the intervention group than the control group. When 
compared to findings in published studies [Cella et al., 2002; Temel et al., 2010], the 
changes seen in our study can be assumed to be clinically meaningful with a mean 
increase in total FACIT-F score of 8.59 (95%CI 2.45 to 14.73; p=0.007) in the ITT 
population and of 10.71 (95%CI 4.49 to 16.94, p=0.001) in the PP population. The most 
distinct improvement was seen in the subscales ‘fatigue’, ‘physical wellbeing’, and 
‘functional wellbeing’. A good QoL consists of a balance between resources, hopes, 
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and burdens, while fatigue is a subjective sensation of weakness, lack of energy, or 
tiredness [Stone et al., 1998]. Fatigue is reported to be the most common complaint 
among cancer patients [Carlson et al., 2004; Duijts et al., 2011]. A recent meta-analysis 
conclude that exercise and psychological interventions are effective for reducing cancer 
related fatigue during and after cancer treatment, and are significant better than the 
available pharmaceutical options [Mustian et al., 2017].  
The STREAM program offers an approach to focus on individual processes to 
adapt to the disease and its fundamental threats. The content includes 
psychoeducation, reflection, and acquisition of coping strategies. Amongst others, 
these include the fostering of a more efficient use of one’s own resources, in line with 
published results that both behavioral techniques and physical exercise improve 
psychosocial functioning and QoL [Duijts et al., 2011].  
Distress measured with the DT at the post-intervention time point was significantly 
lower in the intervention group than the control group (-0.85; 95%CI -1.60 to -0.10; 
p=0.03). Systematic recording of distress and QoL in cancer patients is well established 
[Mehnert et al., 2018; Pearce et al., 2008]. While it is indisputable that QoL is of 
substantial importance, it is inherently difficult to measure [Testa & Simonson, 1996]. 
When interpreting the results, the conceptual overlap with distress caused by the 
existential threat of the illness must be taking into account. The DT itself is a simplified 
and widely used assessment tool of general distress with a single number (VAS 0-10) 
representing distress [National Comprehensive Cancer Network, 2019].  
There has been considerable scientific interest in the psychological adjustment to 
a sudden threat of mortality [Baker et al., 2016; Vehling & Kissane, 2018]. Fears of 
dying, suffering, loss of body parts and functionality, and loss of autonomy play an 
important role during adjustment to the disease [Parle et al., 1996]. Velikova and 
colleagues investigated the impact of recording QoL in cancer patients and concluded 
that attentiveness and feedback are important components of a therapeutic 
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intervention’s effectiveness [Velikova et al., 2004]. Moreover, the authors found that 
regular assessment of QoL itself favorably affected the physician-patient 
communication and resulted in better QoL and emotional functioning in some patients 
[Velikova et al., 2010]. It seems that the regular attention to an individual’s QoL might 
be an effectiveness factor itself. Thus, future attention should be directed towards 
placebo research, which offers a potential for improvement of fatigue [Zhou et al., 2019]. 
Our study did not address this specific question, and further studies specifically focusing 
on these issues are needed.  
For the sake of completeness, the potential positive impact of cancer should be 
mentioned. A severe life event can be an opportunity for positive personal growth as 
well as distress [Aldwin & Sutton, 1998; Parkes, 1971]. The positive aspect of suffering 
from cancer, often referred to as post-traumatic growth, has been gaining interest in the 
last decade. Such post-traumatic growth has been defined as a positive psychological 
change experienced as a result of the struggle with highly challenging life circumstances 
[Calhoun & Tedeschi, 2001]. We did not evaluate the potential of any positive impact of 
the illness on QoL and distress in our randomized, controlled trial.  
Another matter of importance is the timing of administering the intervention. 
STREAM was implemented in the early phase of the course of disease, i.e. at the time 
of starting antitumor therapy. Previous studies suggested that QoL data recorded early 
in the course of disease and treatment are a possible cue for optimized treatment. 
Stickel and Goerling proposed the use of QoL as an early warning system [Stickel & 
Goerling, 2018]. Therefore, interventions targeting QoL at an early stage are of 
substantial interest. Published results indicate that QoL is the most common patient-
recorded outcome showing an association with overall survival in cancer patients [Gotay 
et al., 2008; Quinten et al., 2009]. Moreover, the association between distress and 
cancer was investigated for decades without a clear understanding of the underlying 
mechanism. With the rapid development of successful immunotherapies, these 
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research questions have gained new momentum. Recently, Obradovic et al. published 
data from mice modeling on glucocorticoid receptor activity assuming that stress 
management in breast cancer patients plays a role in survival-time prolongation 
[Obradovic et al., 2019]. Further longitudinal studies are needed to confirm whether 
improved QoL after completion of STREAM translates into improved treatment 
tolerability and/or even favorable disease course.  
Our results may allow estimations about the potential public health impact of the 
STREAM program. Psycho-oncology with specific interventions is gaining increasing 
interest. Within a short time, some promising programs have been developed, 
addressing QoL and distress in cancer patients [Bao et al., 2019; Beatty et al., 2016; 
van den Berg et al., 2015; van den Berg et al., 2012; Willems et al., 2017]. Hummel and 
colleagues developed a promising internet-based CBT addressing sexual functioning 
with improvement in body image. In this trial, no significant effects of distress and QoL 
were found [Hummel et al., 2017]. It is hoped that the successful implementation of 
these programs will provide insight into future possibilities and limitations of psycho-
oncological support delivered online. Moreover, guidelines [Proudfoot et al., 2011] for 
executing studies and reporting data enable researchers to repeat and compare 
studies. This, in turn, may lead to an improvement of programs and patient care in the 
future.  
In conclusion, STREAM offers a comprehensive intervention addressing QoL 
enhancement and distress reduction in cancer patients. STREAM is an alternative to 
face-to-face interventions in the psycho-oncological care landscape. Furthermore, this 
form of support may overcome the resistance to psychological help among patients with 
time constraint and high distress levels as well as those who live in places far removed 
from medical and psychological facilities. 
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5.4 Clinical integration of STREAM 
Digitalization in the healthcare sector is progressing rapidly with a benefit for all 
populations, especially those living far away from medical and psychological facilities. 
As Hesse formulates it, “in theory, the internet should help solve the last mile problem 
by making the best knowledge in the world available to everyone worldwide at a low 
cost and no delay” [Hesse, 2019]. With STREAM, we developed a treatment option 
using online delivery for patients living outside of urban centers. Besides the advantage 
that the internet intervention bridges an actual local distance, it also supports individuals 
in maintaining their subjective boundaries in their contact option with a professional 
therapist. 
Although the reasons for none or ambivalent acceptance of an intervention are 
multifaceted [Tondorf et al., 2018], one important factor for patients to consult a 
professional psycho-oncologist is their personal inhibition threshold. Many patients 
have difficulties in addressing integrity disturbances directly and verbally in a 
professional therapeutic context since they are ashamed of exposing their (perceived) 
weakness [Kaul & Fischer, 2016]. Individuals have a good sense of their own felt 
boundaries as an area defined by unconscious proprioception in its extension, which 
gives them a feeling of security and wholeness [Scaer, 2014]. The perception of 
boundaries comprises a spatial and physical closeness and distance on the one hand 
and an emotional closeness and distance on the other hand [Kaul & Fischer, 2016]. 
For patients with a clear need of support who refuse such help because of their 
intra-individually perceived suffering and integrity disturbance, online therapy may have 
a double benefit. First, more patients may undergo psycho-oncological therapy due to 
a lower inhibition threshold. Second, the effectiveness of their therapy is increased as 
individual contact boundaries are respected due to written contact. Beyond the general 
effect of lowering the inhibition threshold, online therapy may also have specific benefits 
for patients with a life-threatening diagnosis, such as cancer. A cancer diagnosis 
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threatens the fundamental assumptions about a person’s own control of his or her life, 
often leading to the questioning of all aspects of his or her life, including the individual’s 
self-perception of being invulnerable or even immortal [Janoff-Bulman, 1999]. These 
changes might result in “existential distress” [Vehling & Philipp, 2018]. In the course of 
dealing with one's own life or mortality, the known, mostly unconscious regulatory 
patterns of proximity and distance often shift, and patients may find it difficult to continue 
the familiar daily routine that provides security [Salander, 2018].  
In the early course of the disease, the struggle with regulating closeness and 
distance might be worsened by the many hospital and physician visits and difficult 
treatment decisions patients have to make. Patients may fear to lose their autonomy by 
having to accept inpatient stays with reduced privacy and invasive treatments, such as 
drug injections and infusions [Norskov et al., 2019]. The standardized diagnostic and 
therapeutic procedures leave little room for individual decisions since they depend on 
established schemes used by the treatment center. This might result in an "excess" of 
emotional, cognitive, and physical stimuli, and violations of individual needs seem 
inevitable. According to Lazarus and Folkman, the reactions to this are highly individual 
and depend on available coping strategies [Lazarus & Folkman, 1984]. Patients 
experience distress and diminished QoL, which negatively affects their mental health 
[Penedo et al., 2013; Rehse & Pukrop, 2003] and therapy compliance [Chambers et al., 
2012; Park & Gaffey, 2007].  
Under these stressful conditions, an additional appointment with a psycho-
oncologist may not be fully effective as the patient is not receptive to additional 
treatment due to high stress levels. Psycho-oncological online support with minimal 
contact has the benefit to let patients feel more in control of their life. Online therapy 
may therefore be more effective by overcoming the challenges of stress-inducing face-
to-face consultations.  
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The following two statements by participants underline the empowerment factor 
in delivering coping strategies: "The program showed me how to deal better with my 
emotional world, the ups and downs. The modules have given me many very good 
different ways to deal with stress phases". Another participant stated, “It makes me feel 
good to do something for myself and not just do nothing”. Online support in the form of 
STREAM (guided self-help, minimal-contact) represents a good compromise between 
no support at all and regular face-to-face consultations and thus supports patients in 
their self-efficacy in dealing with cancer. Moreover, the tool might support ambivalent 
patients by protecting and respecting their needs for closeness (indigence) and distance 
(autonomy). Online interventions are often accused of sacrificing the important 
therapist-patient relationship. This notion has been refuted in recent years as stated by 
Cuijpers: “It seems safe to conclude that guided self-help and face-to-face treatments 
can have comparable effects. It is time to start thinking about implementation in routine 
care” (p. 1, [Cuijpers et al., 2010]. 
I postulate that respecting the patient’s boundaries – physical and emotional - 
supports an effective therapy. Further research is needed to validate this speculation, 
as our study design was not dedicated to this question. However, our randomized, 
controlled trial achieved exceptionally high adherence values, which may indicate that 
patients were well supported by the minimal-contact format. These promising data 
should encourage new specific research on the balance between closeness and 
distance for effective therapy. 
5.5 Limitations 
The project entitled “Understanding why cancer patients accept or turn down 
psycho-oncological support: A prospective observational study including patients’ and 
clinicians’ perspectives on communication about distress” was a single-center study 
conducted in a large cancer center at a major Swiss university hospital. Single-center 
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studies are common in the medical literature (e.g. [Ellis et al., 2009], and can provide 
valuable heuristic information. However, they may not be representative of the 
population worldwide as they are likely to reflect national and cultural variations. 
A limitation of the STREAM usability pre-study was that we tested it in the 
laboratory, which may not fully represent the use of the program at home. If problems 
occurred during the use of the online program, participants were able to ask for 
assistance. Second, the small sample size may also limit the generalizability of our 
results. However, it is important to note that usability tests are qualitative methods that 
aim to reveal the most important issues that may arise during a patient’s interaction with 
a website. Published literature suggests that the majority of usability problems and flaws 
can be identified in small samples of up to 10 subjects [Tullis & Albert, 2013].  
Shortcomings of the main project entitled “Web-based stress management for 
newly diagnosed cancer patients (STREAM-1): a randomized, wait-list controlled 
intervention study” include the following: First, STREAM was designed for newly 
diagnosed cancer patients. Nevertheless, women with breast cancer undergoing 
curative treatment represented the vast majority of the study population. This renders 
the generalizability of the results questionable, particularly for male patients and 
patients in the palliative setting. There is evidence that also men experience a benefit 
in distress reduction [Wootten et al., 2014b]. Second, more patients in the control group 
than the intervention group reported face-to-face psychological support and use of 
psychotropic drugs at baseline, although the difference was not statistically significant. 
Because we did not collect data on the time spent with psychologists during the trial, 
the potential bias cannot be quantified. Third, we opted for a wait-list (care-as-usual) 
controlled design. A wait-list controlled design is generally accepted to assess the effect 
of time on the outcome of interest. However, the post-intervention assessment time 
points for the control group were rigid and defined prospectively, whereas the post-
intervention assessment time points in the interventions group depended on the 
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duration of the intervention and were therefore more variable. Hence, time sensitivity is 
only partially accounted for. Dynamic wait-list controlled designs have been proposed 
to minimize this potential bias [Brown et al., 2006].  
Another shortcoming of our trial was that we showed a benefit for distress and 
QoL for patients only early after diagnosis with a limited follow-up. It is conceivable, 
however, that such an early intervention [Temel et al., 2010] may be of particular 
importance to prevent chronification of distress [Enns et al., 2013]. The question 
whether reduced distress and improved QoL after STREAM translate into better 
treatment tolerability and favorable disease course warrants additional studies. 
Thereby, it is important to take into account the extent to which psychological 
stress is a risk factor for cancer disease progression, as it is for the development of 
psychological disorders. This includes the investigation of biological variables such as 
cortisol levels, which was found to affect overall survival in breast cancer patients 
[McGregor & Antoni, 2009]. Despite numerous epidemiological studies, the underlying 
mechanism is not yet clarified [Rensing & Rippe, 2009].  
Moreover, we did not consider the potential positive impact of a cancer diagnosis 
itself. Post-traumatic growth has been defined as a positive psychological change and 
adaption as a result of the struggle with highly challenging life circumstances [Calhoun 
& Tedeschi, 2001]. The inclusion of post-traumatic growth will be an important aspect 
for further investigations.  
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5.6 Outlook  
The prevalence of cancer will continue to rise. The incidence in 2030 is estimated 
at over 20 million people worldwide [Arndt et al., 2016; Global Cancer Observatory, 
2019]. Due to the improved treatment options, the number of long-term cancer survivors 
will also increase. The psycho-oncological services are constantly being expanded and 
are routinely offered to and strongly recommended in patients with marked distress. 
This leads to an increasing number of patients seen by a psycho-oncologist. Due to the 
rapid technical changes, online support will continue to grow and will find its way into 
standard care of cancer patients. Moreover, online support modules have a 
considerable potential to support large numbers of cancer patients in a broadly 
accessible and cost-effective manner [McAlpine et al., 2015]. Online minimal-contact 
programs can be used as a source of information, form of communication, and 
therapeutic tool. 
The upcoming ICare project funded by European Union’s Horizon 2020 research 
aims to establish a comprehensive model of promoting mental health in Europe. ICare 
is designed to improve existing healthcare models, open new access paths, and 
overcome traditional implementation barriers. This large project brings together mental 
health experts from all of Europe [Jacobi & Partners, 2019]. Other initiatives are 
currently being developed to tailor information and support to a larger community of 
cancer patients and their relatives (e.g. https://.kanker.nl in the Netherlands, and 
https://lebensheldin.de/ in Germany). In the next few years, it remains to be seen 
whether internet-based support in routine application can confirm the promising 
research results.  
Cancer-related fatigue is one of the five top high-priority research areas 
designated by the National Cancer Institute Clinical Oncology Research Program in the 
United States [Mustian et al., 2017]. STREAM has the potential to be linked to these 
platforms, especially addressing patients suffering from reduced QoL and cancer-
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related fatigue. Currently, we are working on its implementation in the German-speaking 
healthcare sector with the perspective to translate its contents into different languages. 
Since our feasibility and efficacy results for STREAM proved positive [Grossert et al., 
2018], further implementation of the tool and larger clinical studies can now be planned.  
Future investigations of online interventions will aim to complete the picture of 
effectiveness and to better understand underlying processes. Moreover, social change 
with the increasing influence of new technical possibilities will also be reflected in the 
psychological support of patients. In addition, the debate about the daily influence of 
new media and their fast technical development and innovation (e.g. virtual reality, 
artificial intelligence) will continue to challenge individuals, care givers, patients, and the 
entire society. 
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5.7 Conclusion 
Despite improved diagnostic and therapeutic options, the diagnosis of cancer 
remains an enormous threat, and QoL of affected individuals is inevitably impaired. 
Oncology was one of the first areas in which the assessment of health-related QoL was 
systematically measured to describe the patient's condition and functional status during 
the course of disease. Our studies offer a novel method to analyze the supportive care 
needs of cancer patients. The pre-study findings highlighted the importance of 
conducting a professional usability test in the target population during the development 
of an online intervention tool. These assessments were an important step in the 
planning of the randomized, controlled clinical trial. To the best of our knowledge, this 
is the first efficacy study testing a German web-based stress-management intervention 
tool for newly diagnosed cancer patients. The needs of cancer patients and cancer 
survivors are changing continuously, and psycho-oncological support has become a 
standard treatment option. Our results confirmed that web-based self-help guidance 
has the potential to efficiently support and empower newly diagnosed cancer patients 
and hopefully pave the way for new interventions to enrich the psycho-oncology 
landscape. 
 
 
 
 
 
 
 
“A tree with deep roots is not bending by the wind.”  
Korean proverb, author unknown 
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Background
Impact of cancer on mental health
Every second cancer patient suffers from clinically rele-
vant psychosocial distress [1]. Psychosocial distress en-
compasses emotional lability, rearranging of roles and
responsibilities, changing of future plans, fear of recur-
rence, depression and anxiety and is associated with de-
creased quality of life [2–4]. In addition, high levels of
distress lead to reduced compliance with treatment and
more side effects [5, 6]. Conversely, side effects of cancer
treatment like fatigue, nausea and pain may trigger dis-
tress and, therefore, impact psychological adjustment.
Efficacy of psycho-oncological interventions and
Utilization of psycho-oncological support
Cognitive behavioural techniques, including relaxation
techniques [7] and mindfulness based stress reduction
[8], significantly reduce distress, depression and fatigue
and increase quality of life in cancer patients, albeit ef-
fect sizes in randomized controlled trials are small to
medium [9]. Moreover, psycho-oncological interventions
may reduce side effects of cancer treatment [7, 9–13].
Yet many patients do not seek or have access to psycho-
oncological support, even when high levels of distress
are experienced [14]. This seems especially true for male
patients [15, 16] and patients with cancer other than fe-
male breast cancer [15].
Web-based interventions in psycho-oncology
The internet has the potential to reach patients and to
overcome barriers towards using psycho-oncologic sup-
port (e.g. stigma and privacy concerns, geographical dis-
tance form providers, time constraints to adhere to
additional appointments during office hours) [17]. The
vast majority of cancer patients already uses the internet
as a source of information [18]. Furthermore, from the
providers’ perspective, internet interventions are time-
and cost-effective, and thus are of special interest for the
health care system. Scientific interest in internet inter-
ventions for non-cancer patients has grown rapidly over
the last decade. Efficacy of this novel treatment format
has been demonstrated for a variety of mental disorders
in a substantial number of randomized controlled trials
(RCTs). Reviews and meta-analyses show moderate to
large effects, post-treatment [19–22]. Studies directly
comparing internet interventions with face-to-face ther-
apy report similar outcomes across various mental disor-
ders (e.g. anxiety disorders, depression) and health
concerns associated with bodily symptoms (e.g. tinnitus,
sexual dysfunction) [23]. There are also a few long-term
follow-up studies showing lasting effects over as much
as five years post-treatment [24]. Data on web-based in-
terventions for cancer patients are scarce [25, 26]. There
is no cancer-specific stress management program for
cancer patients in German. Also, little is known on the
characteristics (including age, sex, education, type of
cancer) of patients who participate and benefit from a
web-based intervention.
Objective and research questions
In a prospective randomized wait-list controlled trial we
assess the efficacy of a minimal-contact online interven-
tion in newly diagnosed cancer patients. More specific-
ally, we assess whether patients who undergo the online
intervention report a better quality of life (FACIT-F), are
less anxious and depressive (HADS-D), less stressed
(DT), and cope better with their disease (FAH II) as
compared to patients in the wait-list control group. This
is the first online stress management intervention in
German for cancer patients (STREAM: STREss Aktiv
Mindern). Moreover, since it is novel to recruit patients
via the internet rather than face-to-face, we set out to
determine patients characteristics for participation and
benefit. These descriptive outcomes include: patients’
characteristics (type of cancer, type of treatment, socio-
demographic factors), patients’ adherence as well as sat-
isfaction with the program.
Methods/design
In a prospective randomized controlled intervention
study (Fig. 1) patients are randomized 1:1 (mixed
randomization scheme using unequal block
randomization) between the intervention group and the
wait-list control group. Patients are stratified according
to baseline stress level (distress thermometer ≥ vs < 5
[27]). A total of 120 newly diagnosed adult (>18 years)
cancer patients who started first-line treatment (either
systemic treatment - including chemotherapy, hormonal
treatment or targeted therapy - or radiotherapy) no lon-
ger than 12 weeks earlier are included after giving in-
formed consent. Patients who undergo treatment for a
first relapse of a tumor previously treated with curative
intent are also eligible. Patients are required to read and
write in German, have internet-access as well as basic
computer skills.
Patients are recruited via the public website of
STREAM [28]. We adopt an active recruitment strat-
egy in the German speaking countries Switzerland,
Germany, and Austria via the following channels: a)
Links to the public website of STREAM on health
related websites, such as Cancer Leagues, Cancer
Hospitals, Patient advocate websites b) distribution of
flyers in hospitals and during cancer conferences, c)
active communication to the media d) advertisement
via Google Ad and Facebook Ad. The Northwest and
Central Swiss Ethics Committee has approved the
study (EKNZ 339/13).
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Intervention
We developed the web-based intervention STREAM
based on well-described and established stress man-
agement interventions manuals [29–33], which we
adapted to the web-context. The program aims at im-
proving intra- and interpersonal coping strategies, re-
ducing perceived stress and anxiety as well as
enhancing quality of life. We assessed the usability of
the program in the target population of cancer pa-
tients in a previous study (Grossert A, et al. Usability
evaluation of the web-based stress management pro-
gram STREAM for newly diagnosed cancer patients.
submitted. 2016).
STREAM consists of eight modules (Table 1) which
can be completed in 60 to 90 min each. Participants are
asked to work through one module per week, i.e. the
intervention takes 8 weeks in total. Every module starts
with a short mindfulness breathing exercise and includes
(a) text-based psycho-education, (b) reflection on the
current individual emotional status and (c) acquisition of
strategies including several exercises. Within each mod-
ule exercises on relaxation techniques and guided-
imagery exercises are available as audio files and can be
downloaded to various devices (e.g. PC/Mac, tablets,
smart phones, MP3 Players). Patients are encouraged to
use the audio files daily. Participants receive weekly
feedback and individual support by a psychologist from
the study team via secure integrated e-mail (=”minimal-
contact”). Patients can use the secure chat function to
contact the psychologist.
Assessments
Assessments are summarized in Table 2 and are con-
ducted via an open source survey application [34] at
baseline (T1), after the 8-week intervention or wait (con-
trol group), respectively (T2), as well as after an
additional 8 weeks (T3, follow-up for the intervention
group or after the delayed intervention for the wait-list
group, respectively (Fig. 1)).
Socio-demographic information is self-reported and
includes age, gender, marital status and partnership, chil-
dren, education, monthly household income and em-
ployment status.
Medical history includes information regarding tumor
diagnosis, time since diagnosis, past and current cancer
treatments (curative or palliative setting), past and
current psychosocial support and psychopharmacologi-
cal medication and is obtained from both patients and
their treating physicians.
Efficacy outcomes
The main efficacy outcome is quality of life (FACT) in-
cluding assessment of fatigue (FACT-F) [35] at T2. We
use the validated German Version functional assessment
of chronic illness therapy-fatigue (FACIT-F) which is
freely available from the website www.facit.org.
To assess anxiety/depression and psychological
distress the hospital anxiety and depression scale
(HADS) [36] and the distress thermometer (DT) in the
German version [27] are used, respectively. Patients are
stratified based on their level of baseline distress. A
score of five or higher at the DT visual analogue scale is
a cut-off score for a clinically significant level of distress
[27]. To longitudinally describe psychological coping
with cancer we use ‘the acceptance and action question-
naire (AAQ)’ in its German version ‘Fragebogen zur
Akzeptanz und Handeln (FAH II)’ [37], which we
adapted specifically for cancer patients with three add-
itional items concerning their coping with the disease.
The online support program STREAM is not designed
to support suicidal patients in acute crises. For safety
reasons, suicidal tendency is assessed by the single sui-
cide item out of the Beck Depression Inventory (BDI)
[38]. Patients with a score higher than one are contacted
by telephone to reassess suicidal ideation and, if needed,
patients are instructed to call for local psychiatric
support.
Fig. 1 Study design
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Evaluation of the intervention
To evaluate the therapeutic alliance between patient and
therapist the short version of the working alliance
inventory (WAI-SR) with subscales for bond, tasks and
goals is used in its German version [39] weekly after
each module. Usability and user satisfaction is assessed
with the system usability scale (SUS) [40] and the
Client Satisfaction Questionnaire (CSQ-8; in its German
version: Fragebogen zur Messung der Patientenzufrieden-
heit ZUF-8; [41]. Satisfaction with the online therapeutic
contact will be assessed with predefined questions de-
scribed by Knaevelsrud and Maerker [42]. In addition,
after each module, patients’ satisfaction with the module
is assessed with an open question. Data on adherence
(frequency and duration of logins, website activity,
using/downloading different exercises, and the number
of modules completed) are collected via the backend
functions of the online program STREAM.
Statistical analyses and sample size calculation
Based on previous studies [43] including recent data on
cancer patients [44], a difference of nine points in the
FACT score is both, clinically significant and realistic. In
order to demonstrate a 9-point difference between base-
line and T2 (after 8 weeks) in the intervention group
with a statistical power of 0.80 at a significance level of
0.05 (two-sided), 60 participants are needed in each of
the two conditions. We assume normally distributed
data in both groups with a standard deviation of ±18
[45]. Data preparation of all continuous dependent
Table 1 Content of the web-based stress management program STREAM
Module Psychoeducation Reflection on status Strategies
1. Introduction: What is stress? Nature of stress in general and in
specific cancer-related situations
My individual stressors Diaryb
Stress protocol Body scana
Stress protocol b
2. Body stress reduction Bodily sensations during stress and
side effects of anticancer treatment
Relaxation protocol Progressive muscle relaxation a
Beach promenadea
Relaxation protocolb
3. Cognitive stress reduction Thoughts and their interaction with
emotions and bodily sensations
My negative thought
patterns
Negative thought cyclea
Relationship of body position
and thoughtsb
Thinking styles and reflectionb
Thoughts on cloudsa
4. Emotional stress reduction Feelings and cancer-related emotions
as anxiety and worries were explained
My feelings and worries Mountain meditationa
Emotional emergency kita
5. Mindfulness and acceptance of
thoughts and emotions
Meaning of mindfulness and acceptance
and their implementation in daily life in
contrast to the active strategies learned
in modules 1–4
My definition and
experiences with acceptance
Acceptance story a,b
Body scana,b
Integration of mindfulnessb
Winter walka
Spring awakeninga
6. Activation of resources: quality of
life and pleasure
Introduction of models of the balance
between burden and resources
My individual resources Health-cycle b
Planning activitiesb
Week planner b
Friendly feelings with our
own bodya
Enjoyment trainingb
7. Activation of resources: social
network and communication skills
Social network and the role of a
supportive environment
My individual social network
and current needs
Communication skillsb
Beach promenadea
Winter promenadea
Spring awakeninga
8. Summary Concluding an overview and
documentation of the last 7 weeks
My experiences with the
program
Four seasonsa
aAudio file: story, relaxation or guided imaginary exercise, bInstructions and worksheets
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variables will include tests for normality, homogeneity of
variances, and examination of outliers. If not normally
distributed, variables will be subjected to adequate trans-
formation. Intent-to-treat samples will be used to
analyze data. The choice of statistical approach depends
on the amount of missing data at T2 and T3. If less than
12 % of data are missing, the Last Observation Carried
Forward (LOCF) method will be applied to estimate ef-
fects. Then, the outcome will be computed with an ana-
lysis of covariance (ANCOVA), using the pre-scores as a
covariate and the post-scores as the dependent variable.
If more than 12 % of data are missing, we will use linear
mixed models. This method is recommended for intent-
to-treat-analyses with a high amount of dropouts due to
its potential to reduce bias caused by missing data. Re-
gression analyses will be used to identify predictors of
treatment outcome.
Discussion
Psychological distress associated with cancer diagnosis
and treatment is high. Yet, psycho-oncological support
is often lacking –due to barriers on the patients’ side or
to insufficient resources on the providers’ side [15].
Online-interventions with regular psychologist-contact
(minimal-contact) -already established in several psycho-
logical disorders- might reduce this gap. In our pro-
spective, randomized controlled study we assess the first
minimal-contact, online stress management program for
German-speaking, newly diagnosed cancer patients.
Our study will yield information on the efficacy of the
intervention with respect to quality of life and stress/
anxiety. In addition, it will show whether cancer patients
are ready to use new technologies to further increase the
range of treatment options at their disposal, and -even
more importantly- whether patients who are in need of
support but slip through the net of the current system
can be reached. Conversely, the time- (and indirectly the
cost-) effectiveness of administering support in a
minimal-contact online intervention will be assessed
from the providers’ perspective – an outcome with im-
portant implications for the health care system.
On a different level, the contribution of various and
novel recruitment strategies (flyers, “conventional face-
to-face”, internet links, Google Ads, Facebook Ads, You
tube) will be described allowing for conclusions for fu-
ture online study portals.
One of the limitations of the study is the heterogeneity
of newly diagnosed cancer patients with respect to
tumor type, treatment type and treatment strategies
(curative, palliative). However, the distress of a new can-
cer diagnosis is their common denominator, and a strati-
fication factor. Also, since this is the first online stress
management program for newly diagnosed cancer pa-
tients, we deliberately aim at reaching a broad popula-
tion to avoid missing a small but important group of
patients with potential benefit from this intervention.
The results of this study will allow characterizing the pa-
tient population(s) with respect to age, sex, diagnosis
and treatment that will then be studied more specifically
in follow-up trials. Our trial represents a first step in
expanding the much-needed psychological support for
newly diagnosed cancer patients towards the promising
approaches that come with new technical possibilities
which have become integral part of our lives.
Trial status
Trial start date: 1th July 2014; Currently recruiting
(Ncurrent = 80 as of March 17, 2016).
Abbreviations
AAQ: Acceptance and action questionnaire; ANCOVA: Analysis of covariance;
BDI: Beck depression inventory; CSQ: Client satisfaction questionnaire;
DT: Distress thermometer; FACIT-F: German Version Functional Assessment of
Table 2 Schedule of assessment
Instrument T1 T2 T3
Baseline Weekly
during
intervention
Post intervention Follow up
Socio-demographics x
Medical history x x x
Distress Thermometer (DT) x x x x
Functional Assessment of Chronic Illness Therapy-Fatigue (FACT-F) x x x
Hospital anxiety and depression scale (HADS) x x x
Suicidal tendency (Suicid Item Beck Depression Inventory BDI) x x x
Acceptance and Action Questionnaire (AAQ) x x x
Working Alliance Inventory (WAI-SR) x
System Usability Scale (SUS) xa
Client Satisfaction Questionnaire (CSQ-8) xb xb
a Assessed twice (after the first and last module); b Assessed post-intervention: for intervention group to T2, for control group to T3
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Chronic Illness Therapy-Fatigue; FACT (−F): Functional Assessment of Cancer
Therapy including Fatigue; FAH II: Fragebogen zur Akzeptanz und Handeln;
HADS: Hospital anxiety and depression scale; LOCF: Last observation carried
forward; RCT: Randomized controlled trial; STREAM: STREss Aktiv Mindern;
SUS: System usability scale; WAI-SR: Short version working alliance inventory;
ZUF-8: Fragebogen zur Messung der Patientenzufriedenheit
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